<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Nutr</journal-id><journal-id journal-id-type="iso-abbrev">Br. J. Nutr</journal-id><journal-id journal-id-type="publisher-id">BJN</journal-id><journal-title-group><journal-title>The British Journal of Nutrition</journal-title></journal-title-group><issn pub-type="ppub">0007-1145</issn><issn pub-type="epub">1475-2662</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26134388</article-id><article-id pub-id-type="pmc">4531470</article-id><article-id pub-id-type="doi">10.1017/S0007114515001786</article-id><article-id pub-id-type="pii">S0007114515001786</article-id><article-id pub-id-type="publisher-id">00178</article-id><article-categories><subj-group subj-group-type="heading"><subject>Full Papers</subject></subj-group><subj-group subj-group-type="section"><subject>Human and Clinical Nutrition</subject></subj-group></article-categories><title-group><article-title>Dietary modulation of the gut microbiota &#x02013; a randomised controlled trial in
obese postmenopausal women</article-title><alt-title alt-title-type="left-running">L. K. Brahe <italic>et al.</italic></alt-title><alt-title alt-title-type="right-running">Dietary modulation of obese gut
microbiota</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Brahe</surname><given-names>Lena K.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="author-notes" rid="fn01">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Le Chatelier</surname><given-names>Emmanuelle</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref><xref ref-type="author-notes" rid="fn01">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Prifti</surname><given-names>Edi</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Pons</surname><given-names>Nicolas</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kennedy</surname><given-names>Sean</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bl&#x000e6;del</surname><given-names>Trine</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>H&#x000e5;kansson</surname><given-names>Janet</given-names></name><xref ref-type="aff" rid="aff003">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Dalsgaard</surname><given-names>Trine Kastrup</given-names></name><xref ref-type="aff" rid="aff004">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hansen</surname><given-names>Torben</given-names></name><xref ref-type="aff" rid="aff005">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Pedersen</surname><given-names>Oluf</given-names></name><xref ref-type="aff" rid="aff005">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Astrup</surname><given-names>Arne</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ehrlich</surname><given-names>S. Dusko</given-names></name><xref ref-type="aff" rid="aff002">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Larsen</surname><given-names>Lesli H.</given-names></name><xref ref-type="aff" rid="aff001">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label> 1 </label><addr-line>Department of Nutrition, Exercise and Sports</addr-line>, <institution>Faculty of
Science, University of Copenhagen</institution>, <addr-line>Rolighedsvej 26</addr-line>,
<addr-line>1958</addr-line><addr-line>Frederiksberg C</addr-line>, <country>Denmark</country></aff><aff id="aff002"><label> 2 </label><institution>INRA, Institut National de la Recherche Agronomique</institution>,
<addr-line>US 1367 Metagenopolis</addr-line>, <addr-line>Jouy-en-Josas</addr-line>,
<country>France</country></aff><aff id="aff003"><label> 3 </label><institution>Arla Strategic Innovation Centre</institution>,
<addr-line>Stockholm</addr-line>, <country>Sweden</country></aff><aff id="aff004"><label> 4 </label><addr-line>Department of Food Science</addr-line>, <institution>Faculty of Science and
Technology, Aarhus University</institution>, <addr-line>Aarhus</addr-line>,
<country>Denmark</country></aff><aff id="aff005"><label> 5 </label><institution>Novo Nordisk Foundation Centre for Basic Metabolic Research, University of
Copenhagen</institution>, <addr-line>Copenhagen</addr-line>, <country>Denmark</country></aff><author-notes><corresp id="cor001"><label>*</label><bold>Corresponding author:</bold> L. H. Larsen, fax +45 353 32470, email <email xlink:href="lehla@nexs.ku.dk">lehla@nexs.ku.dk</email></corresp><fn id="fn01"><label>&#x02020;</label><p>These authors contributed equally to the work presented.</p></fn></author-notes><pub-date pub-type="ppub"><day>14</day><month>8</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>02</day><month>7</month><year>2015</year></pub-date><volume>114</volume><issue>3</issue><fpage>406</fpage><lpage>417</lpage><history><date date-type="received"><day>07</day><month>7</month><year>2014</year></date><date date-type="rev-recd"><day>23</day><month>3</month><year>2015</year></date><date date-type="accepted"><day>22</day><month>4</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; The Authors 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>The Authors</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p><!--CREATIVE COMMONS-->This is an Open Access article, distributed under the terms of the Creative
Commons Attribution licence (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>), which permits
unrestricted re-use, distribution, and reproduction in any medium, provided the original
work is properly cited.</license-p></license></permissions><abstract abstract-type="normal"><p>The gut microbiota has been implicated in obesity and its progression towards metabolic
disease. Dietary interventions that target the gut microbiota have been suggested to
improve metabolic health. The aim of the present study was to investigate the effect of
interventions with <italic>Lactobacillus paracasei</italic> F19 or flaxseed mucilage on
the gut microbiota and metabolic risk markers in obesity. A total of fifty-eight obese
postmenopausal women were randomised to a single-blinded, parallel-group intervention of
6-week duration, with a daily intake of either <italic>L. paracasei</italic> F19
(9&#x000b7;4&#x000a0;&#x000d7;&#x000a0;10<sup>10</sup> colony-forming units), flaxseed mucilage (10&#x000a0;g) or placebo.
Quantitative metagenomic analysis of faecal DNA was performed to identify the changes in
the gut microbiota. Diet-induced changes in metabolic markers were explored using adjusted
linear regression models. The intake of flaxseed mucilage over 6 weeks led to a reduction
in serum C-peptide and insulin release during an oral glucose tolerance test
(<italic>P</italic>&#x0003c;&#x000a0;0&#x000b7;05) and improved insulin sensitivity measured by Matsuda
index (<italic>P</italic>&#x0003c;&#x000a0;0&#x000b7;05). Comparison of gut microbiota composition at
baseline and after 6 weeks of intervention with flaxseed mucilage showed alterations in
abundance of thirty-three metagenomic species (<italic>P</italic>&#x0003c;&#x000a0;0&#x000b7;01), including
decreased relative abundance of eight <italic>Faecalibacterium</italic> species. These
changes in the microbiota could not explain the effect of flaxseed mucilage on insulin
sensitivity. The intake of <italic>L. paracasei</italic> F19 did not modulate metabolic
markers compared with placebo. In conclusion, flaxseed mucilage improves insulin
sensitivity and alters the gut microbiota; however, the improvement in insulin sensitivity
was not mediated by the observed changes in relative abundance of bacterial species.</p></abstract><kwd-group><kwd>Gut microbiota</kwd><kwd>Probiotics</kwd><kwd>Flaxseed mucilage</kwd><kwd>Obesity-related disease</kwd><kwd>Metagenomics</kwd></kwd-group></article-meta><notes><p><bold>Abbreviations:</bold> ANGPTL4, angiopoietin-like protein 4; hsCRP, high-sensitivity
C-reactive protein; LBP, lipopolysaccharide-binding protein; MetaHit, Metagenomics of the
Human Intestinal Tract; MGS, metagenomic species; OGTT, oral glucose tolerance test; T2D,
type 2 diabetes</p></notes></front><body><p>More than half a billion people are obese worldwide, causing an estimated 2&#x000b7;8 million deaths
each year due to metabolic comorbidities, such as CVD and type 2 diabetes (T2D)<sup>(</sup>
<xref rid="ref1" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>)</sup>. Metagenomic studies have suggested that obesity-related metabolic diseases are
accompanied by alterations in gut bacteria gene composition and abundance<sup>(</sup>
<xref rid="ref2" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup>. Noticeably, microbial genes seem to be a stronger predictor of T2D than common
anthropometric risk markers<sup>(</sup>
<xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup> and variation in the human genome<sup>(</sup>
<xref rid="ref3" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>)</sup>, as shown in European and Chinese individuals, respectively, although the most
discriminatory microbial genes differed between the Chinese<sup>(</sup>
<xref rid="ref3" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>)</sup> and European individuals<sup>(</sup>
<xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup>.</p><p>Still, it is not clear whether shifts in the gut microbiota can cause metabolic diseases, or
if they are just a consequence. However, causality is suggested by studies in germ-free
mice<sup>(</sup>
<xref rid="ref8" ref-type="bibr">
<sup>8</sup>
</xref>
<sup>,</sup>
<xref rid="ref9" ref-type="bibr">
<sup>9</sup>
</xref>
<sup>)</sup>, and one study in human subjects<sup>(</sup>
<xref rid="ref10" ref-type="bibr">
<sup>10</sup>
</xref>
<sup>)</sup>. These studies have shown that transplantation of gut microbiota can induce
modifications in the microbiota of the receiving host, associated with either impaired or
improved metabolic health, depending on the phenotype of the donor. Studies in human subjects
that have measured diet-induced alterations in gut metagenomic and whole-body metabolic
markers simultaneously have shown that modifications in the microbiota are accompanied by
improvements in glucose homeostasis and lipid metabolism<sup>(</sup>
<xref rid="ref11" ref-type="bibr">
<sup>11</sup>
</xref>
<sup>,</sup>
<xref rid="ref12" ref-type="bibr">
<sup>12</sup>
</xref>
<sup>)</sup>. Together, these studies suggest that the gut microbiota constitute a promising
target in the prevention of metabolic diseases.</p><p>Food components that directly target the gut microbiota include pre- and probiotics.
Probiotics are living micro-organisms that, when ingested, provide health benefits, either
directly through interactions with host cells or indirectly through effects on other bacterial
species<sup>(</sup>
<xref rid="ref13" ref-type="bibr">
<sup>13</sup>
</xref>
<sup>)</sup>. Common probiotics include <italic>Lactobacillus</italic> species<sup>(</sup>
<xref rid="ref14" ref-type="bibr">
<sup>14</sup>
</xref>
<sup>)</sup>, and <italic>Lactobacillus paracasei</italic> has previously been associated with
a healthy metabolic profile<sup>(</sup>
<xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref>
<sup>,</sup>
<xref rid="ref16" ref-type="bibr">
<sup>16</sup>
</xref>
<sup>)</sup>. Prebiotics are dietary fibres that are selectively fermented by the gut bacteria
and induce specific changes in the composition and/or activity of the gut microbiota that
provide benefits to host health<sup>(</sup>
<xref rid="ref17" ref-type="bibr">
<sup>17</sup>
</xref>
<sup>)</sup>. Flaxseed (<italic>Linum usitatissimum</italic> L.) contains approximately 30&#x000a0;%
of dietary fibres, of which one-third are soluble viscous fibres (mucilage)<sup>(</sup>
<xref rid="ref18" ref-type="bibr">
<sup>18</sup>
</xref>
<sup>)</sup> that induce beneficial effects on glucose homeostasis and lipid metabolism in
human subjects<sup>(</sup>
<xref rid="ref19" ref-type="bibr">
<sup>19</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref21" ref-type="bibr">
<sup>21</sup>
</xref>
<sup>)</sup>. Flaxseed fibres have been shown to be highly fermentable in rats<sup>(</sup>
<xref rid="ref22" ref-type="bibr">
<sup>22</sup>
</xref>
<sup>)</sup>; however, it is not known whether beneficial metabolic effects of flaxseed
mucilage on human subjects can be explained by modulation of the gut microbiota.</p><p>The aim of the present study was to explore the effect of dietary interventions either with
<italic>L. paracasei</italic> F19 or with flaxseed mucilage on gut microbiota and metabolic
risk markers in obese postmenopausal women.</p><sec sec-type="materials|methods" id="sec1"><title>Materials and methods</title><p>A total of fifty-eight women were randomised to a parallel-group intervention of 6 weeks'
duration with a daily intake of <italic>L. paracasei</italic> ssp.
<italic>paracasei</italic> F19, flaxseed mucilage or placebo (<xref ref-type="fig" rid="fig1">Fig. 1</xref>). The participants were blinded to their allocation; <italic>L.
paracasei</italic> F19 was mixed with maltodextrin and administered in sachets and the
indistinguishable placebo product was administered in sachets with a corresponding dose of
maltodextrin. Flaxseed mucilage was administered in breakfast buns and the corresponding
placebo products were buns without flaxseed mucilage.<fig id="fig1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Illustration of the 6-week parallel-group intervention, with participants randomised
to one of the three different diet groups.</p></caption><graphic xlink:href="S0007114515001786_fig1"/></fig>
</p><p>The primary outcomes were the effect on the gut microbiota composition and insulin
sensitivity; the secondary outcomes were the effect on the inflammatory markers, blood
lipids and fat mass distribution. Enrolment of participants was performed continuously by
the same two researchers, and randomisation was carried out continuously using pre-prepared
opaque sealed envelopes with an equal allocation ratio of 1:1:1. Sample size calculations
were based on preliminary results from a subgroup of Danish participants in the Metagenomics
of the Human Intestinal Tract (MetaHIT) study<sup>(</sup>
<xref rid="ref5" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>)</sup>. With a sample size of eighteen participants per group, a statistical power of
80&#x000a0;%, a two-sided significance level of 0&#x000b7;05 and with the assumption of equal variances, the
study will identify the changes between independent groups in gut microbiota composition
corresponding to 1&#x000a0;<sc>sd</sc>, e.g. a difference of 40&#x000a0;000 gene counts will be identified
if the <sc>sd</sc> is 40&#x000a0;000 gene counts, and similarly, a 0&#x000b7;5 difference in insulin
sensitivity (homeostatic model assessment of insulin resistance, HOMA-IR) will be identified
for an <sc>sd</sc> of 0&#x000b7;5.</p><p>The participants attended a screening visit within the 2 weeks before randomisation and
four visits after enrolment: visit 1 at baseline (day 0); visit 2 at day 28 of the
intervention; visit 3 at the end of the intervention (day 42) and visit 4 4 weeks after the
end of the intervention. After the completion of the study, the participants were offered a
10-week weight reduction programme. During the visits, blood was drawn, faecal samples were
collected, body composition and blood pressure were measured, and information on dietary
intake, physical activity level and adverse events were obtained. The present analyses
included the 6-week intervention period that was the primary outcome of the study.</p><sec id="sec1-1"><title>Study population</title><p>Participants were recruited from the Copenhagen area through advertisements in newspapers
and relevant web sites. The inclusion criteria were women aged 40&#x02013;70 years, &#x02265;&#x000a0;1 year since
last menstruation, BMI of 30&#x02013;45&#x000a0;kg/m<sup>2</sup>, waist circumference &#x0003e;80&#x000a0;cm and
leucocyte blood count &#x0003e;4&#x000b7;7&#x000a0;&#x000d7;&#x000a0;10<sup>9</sup> cells/l. The exclusion criteria were
gastrointestinal diseases, chronic diseases (such as type 1 diabetes or liver cirrhosis),
medically treated T2D or dyslipidaemia, intake of antibiotics within the previous 3
months, intake of supplementary pro- or prebiotics or abnormal high quantities of
fermented foods (&#x0003e;400&#x000a0;g/d) in the previous 6 weeks, or inability to comply with the
research protocol. The present study took place at the Department of Nutrition, Exercise
and Sports, Faculty of Sciences, University of Copenhagen, Denmark, from September 2011 to
September 2012.</p><p>The present study was conducted according to the guidelines laid down in the Declaration
of Helsinki, and all procedures involving human participants were approved by the Ethics
Committee for the Capital Region of Denmark (journal H-3-2011-067). Written informed
consent was obtained from all participants. The present study was registered at
ClinicalTrial.gov (NCT01433120).</p></sec><sec id="sec1-2"><title>Intervention</title><p>The probiotic product contained <italic>L. paracasei</italic> F19 (9&#x000b7;4&#x000a0;&#x000d7;&#x000a0;10<sup>10</sup>
colony-forming units/dose). The probiotic and the placebo (pure maltodextrin) sachets were
indistinguishable. The products were stored at &#x02212;&#x000a0;80&#x000b0;C until the weekly supply to the
participants, after which they were stored in their personal freezer at &#x02212;&#x000a0;18&#x000b0;C until
consumption. Participants dissolved the entire content of the sachet in a glass of water
and consumed it in the morning. Bacterial viability was confirmed at the end of the
intervention by anaerobic culture tests of a sample of the products. Dilution of samples
was spread on deMan, Rogosa and Sharpe (MRS) pH 5&#x000b7;4 agar. Plates were incubated
anaerobically 72&#x000a0;h at 37&#x000b0;C. All characteristic colonies were checked by microscopy and
counted (Arla Foods amba).</p><p>Flaxseed mucilage was extracted from whole flaxseed under heat treatment (Biogin
Biochemicals Company Limited). Breakfast buns based on wheat with and without flaxseed
mucilage were produced by the Department's experimental kitchen, and the daily amount of
flaxseed mucilage administered to the active group was 10&#x000a0;g (5&#x000a0;g/bun). The products were
stored at &#x02212;&#x000a0;18&#x000b0;C at the Department until the weekly supply to the participants. The
intervention and placebo buns were comparable in visual appearance, taste and
macronutrient composition. They were consumed during the morning hours. The participants
were otherwise instructed to maintain habitual dietary habits.</p><p>Participants were required to keep a diary of their intake of study products, and these
were collected at the weekly visits at the Department. A compliance score was calculated
as the percentage of the prescribed test products a participant reported to have consumed
during the 6 weeks of intervention. The participants were interviewed about all types of
potential adverse effects at each visit by the use of broad, open-ended questions; in
addition, they were asked specifically to changes in stool characteristics (consistency
and frequency).</p></sec><sec id="sec1-3"><title>Body composition, dietary and activity records</title><p>Body composition was assessed by dual-energy X-ray absorptiometry (iDXA; Lunar Radiation
Company), BMI (kg/m<sup>2</sup>), waist circumference and intra-abdominal adipose tissue
(cm<sup>2</sup>: &#x02212;&#x000a0;208&#x000b7;2+4&#x000b7;62 (sagittal diameter, cm)+0&#x000b7;75 (age, years)+1&#x000b7;73 (waist,
cm)+(0&#x000b7;78 (trunk fat, %)))<sup>(</sup>
<xref rid="ref23" ref-type="bibr">
<sup>23</sup>
</xref>
<sup>)</sup>. Registration of 3&#x000a0;d weighed dietary intake and physical activity level were
performed within the week before each visit. A registered dietitian analysed all dietary
records using the Danish dietary software program (Dankost Pro). Physical activity was
registered using the Physical Activity Scale<sup>(</sup>
<xref rid="ref24" ref-type="bibr">
<sup>24</sup>
</xref>
<sup>)</sup> where the metabolic equivalent value is calculated based on the time spent on
nine different intensity levels ranging from sleep to very strenuous activities during
24&#x000a0;h.</p></sec><sec id="sec1-4"><title>Biochemical analyses</title><p>Fasting blood samples were obtained after an overnight fast followed by an oral glucose
tolerance test (OGTT) where 75&#x000a0;g of glucose were dissolved in 300&#x000a0;ml of water and consumed
within 5&#x000a0;min. During the OGTT, blood samples were taken with 30&#x000a0;min intervals for 3&#x000a0;h to
ensure return to baseline values. Blood for glucose analysis was collected in iced sodium
fluoride tubes. Blood samples for the analysis of leucocytes count, high-sensitivity
C-reactive protein (hsCRP), lipopolysaccharide-binding protein (LBP), IL-6 and
angiopoietin-like protein 4 (ANGPTL4) were drawn in iced EDTA tubes. Blood samples for all
other analyses were collected in non-coated tubes. Blood samples were centrifuged for
10&#x000a0;min at 2500&#x000a0;<italic><bold>g</bold></italic> at 4&#x000b0;C and kept at &#x02212;&#x000a0;80&#x000b0;C until analyses were performed. Insulin resistance was
assessed by glucose, insulin and C-peptide at the fasting and stimulated state.
Inflammatory state was assessed by leucocytes count, hsCRP, TNF-&#x003b1;, IL6 and LBP. Lipid
metabolism was assessed by measurement of serum concentrations of total cholesterol,
LDL-cholesterol, HDL-cholesterol and TAG, and plasma concentration of ANGPTL4. ABX Pentra
400 (Horiba ABX) was used to analyse glucose (intra- and inter-assay CV: 1&#x000b7;1 and 1&#x000b7;5&#x000a0;%),
TAG (intra- and inter-assay CV: 3&#x000b7;8 and 3&#x000b7;0&#x000a0;%), total cholesterol (intra- and inter-assay
CV: 1&#x000b7;0 and 1&#x000b7;7&#x000a0;%), HDL-cholesterol (intra- and inter-assay CV: 1&#x000b7;2 and 2&#x000b7;7&#x000a0;%),
LDL-cholesterol (intra- and inter-assay CV: 1&#x000b7;3 and 3&#x000b7;3&#x000a0;%) and hsCRP (intra- and
inter-assay CV: 3&#x000b7;6 and 6&#x000b7;5&#x000a0;%). Immulite 1000 (Siemens Medical Solutions Diagnostics) was
used to analyse insulin (intra- and inter-assay CV: 4&#x000b7;2 and 7&#x000b7;3&#x000a0;%) and C-peptide (intra-
and inter-assay CV: 6&#x000b7;9 and 5&#x000b7;2&#x000a0;%). Sysmex KX-21 hematology (Sysmex GmbH) was used to
analyse the leucocytes count (intra- and inter-assay CV: 2&#x000b7;0 and 1&#x000b7;4&#x000a0;%). LBP (intra- and
inter-assay CV: 6&#x000b7;1 and 9&#x000b7;8&#x02013;17&#x000b7;8&#x000a0;%) was analysed with a human LBP Elisa kit (Abnova).
TNF-&#x003b1; (intra- and inter-assay CV: 5&#x000b7;4 and 6&#x000b7;1&#x000a0;%), IL-6 (intra- and inter-assay CV: 7&#x000b7;4 and
8&#x000b7;5&#x000a0;%) and ANGPTL4 (intra-assay CV: 3&#x000b7;8&#x000a0;%) were analysed with ELISA (antibodies were
purchased from R&#x00026;D Systems). Insulin resistance was estimated by HOMA-IR<sup>(</sup>
<xref rid="ref25" ref-type="bibr">
<sup>25</sup>
</xref>
<sup>)</sup>. Data from the OGTT were evaluated by AUC analysis and by the Matsuda
index<sup>(</sup>
<xref rid="ref26" ref-type="bibr">
<sup>26</sup>
</xref>
<sup>)</sup>.</p></sec><sec id="sec1-5"><title>Stool samples and microbiota analyses</title><p>Participants collected samples of faeces in two 20&#x000a0;ml tubes (samples A and B) within 2&#x000a0;d
before the visit. The samples were either stored immediately at &#x02212;&#x000a0;80&#x000b0;C or briefly stored
in personal &#x02212;&#x000a0;18&#x000b0;C freezers before transport to the laboratory in cooled containers. Total
faecal DNA from the fifty-three participants who completed the dietary intervention was
extracted, sequenced and analysed by quantitative metagenomics at Metagenopolis (INRA). To
obtain homogenous representation of all bacterial species, DNA extraction involved use of
quenching solutions that protect DNA potentially prematurely released by lysis of fragile
cells from degradation by DNases present in the stools and a bead-beating step that
assures lysis of particularly robust cells<sup>(</sup>
<xref rid="ref27" ref-type="bibr">
<sup>27</sup>
</xref>
<sup>,</sup>
<xref rid="ref28" ref-type="bibr">
<sup>28</sup>
</xref>
<sup>)</sup>. A Barcoded Fragment Library was prepared for each sample and DNA sequencing
data were generated using the SOLiD 5500xl sequencers (Life Technologies). An average of
65 (<sc>sd</sc> 48) million 50-base-long single reads was determined for each sample.</p><p>Primary data analyses, from reads to generation of a raw count matrix, were performed
using METEOR Studio pipeline for quantitative metagenomic profiling developed at INRA
MetaGenoPolis based on the iMOMi database. Reads generated from the SOLiD sequencer were
trimmed to thirty-five bases and then mapped on the reference catalogue of 3&#x000b7;3 million
genes<sup>(</sup>
<xref rid="ref29" ref-type="bibr">
<sup>29</sup>
</xref>
<sup>)</sup> using Bowtie software with a maximum of three mismatches and selection of the
best hit. If multiple alignments were found, counts were divided equally between the
aligned genes. Using both thirty-five bases reads and three maximum mismatches allows to
take into account the strain variability and the non-redundant nature of the gene
catalogue where redundant open reading frames were removed using a criterion of 95&#x000a0;%
identity over 90&#x000a0;% of the shorter open reading frame length. Average of 38 (<sc>sd</sc>
14) million reads per sample was thus mapped and used to construct a raw gene count
matrix.</p><p>Secondary analyses, from matrix normalisation to microbiota analyses, were performed
using MetaOMineR package, an analytical suite (R language) developed at the INRA
MetaGenoPolis<sup>(</sup>
<xref rid="ref4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="ref5" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>)</sup> that contains different algorithms and routines to normalise and analyse raw
gene count matrixes to extract biological signals. To decrease technical bias due to
different sequencing depth, 24 million reads were randomly selected for each sample using
a draw without replacement. Abundance of each gene in a sample was normalised by dividing
the number of reads that uniquely mapped to a gene by its nucleotide length. Then,
normalised gene abundance was transformed in to frequencies by dividing with 24 million
(see online Supplementary Fig. S1). The resulting set of gene frequencies, the microbial
gene profile of an individual, was used for further analyses.</p><p>Microbial gene richness was measured by counting the number of genes that are present for
a given sample using a downsized count matrix as performed in the original studies<sup>(</sup>
<xref rid="ref4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="ref5" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>)</sup>. To be able to compare the present study and the former ones, we used the
same method, estimating gene count richness using at 11 million unique reads matrix and a
gene richness categorical variable computed by applying a threshold of 480&#x000a0;000 bacterial
genes, to distinguish low from high gene count<sup>(</sup>
<xref rid="ref4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="ref5" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>)</sup>. A prediction model for bacterial richness based on the six bacterial species
was applied in a receiver operating characteristic analysis as described previously<sup>(</sup>
<xref rid="ref5" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>)</sup>, computing the sum of mean abundance of species with greater abundance in
high gene count than in low gene count minus the sum of those with greater abundance in
low gene count than in high gene count. Richness was estimated using either shared or
unique matrix downsized matrices, and either gene count for richness or richness index
such as exponential of Shannon richness index or inverse Simpson index.</p><p>Differentially abundant genes between both time points were selected for each diet using
paired Wilcoxon test (<italic>P</italic>&#x0003c;&#x000a0;0&#x000b7;01), then clustered into metagenomic
species (MGS), using the method based on binning co-abundant genes across all individuals
samples reported previously<sup>(</sup>
<xref rid="ref5" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>)</sup>. To verify that the genes from a given cluster belonged to the same genome
and to annotate the MGS taxonomically, we performed blastN and blastP analyses using a
collection of 6006 genomes (the available reference genomes from the National Center for
Biotechnology Information and the set of draft gastrointestinal genomes from the Data
Analysis and Coordination Center of the HMP and MetaHIT (3 August 2012 version)). MGS were
assigned to a given genome when more than 80&#x000a0;% of the genes matched the same genome using
blastN, at a threshold of 95&#x000a0;% identity over 90&#x000a0;% of gene length. The remaining MGS were
annotated using blastP analysis and assigned to a given taxonomical level from genus to
super kingdom level if more than 80&#x000a0;% of their genes had the same level of assignment.
Data were indexed in a relational database permitting downstream access to genes, gene
function, phylogeny and covariation analysis.</p></sec><sec id="sec1-6"><title>Quantification of SCFA using the ethyl chloroformate-NEFA method</title><p>For the quantification of SCFA, approximately 10&#x000a0;g of stool were mixed with an equal
amount of deionised H<sub>2</sub>O (18&#x000b7;2&#x000a0;M&#x003a9;) filtered water (0&#x000b7;22&#x000a0;mm). Sample preparation,
analyses by the ethyl chloroformate NEFA method and GC, were performed by applying methods
described in detail by Amer <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref30" ref-type="bibr">
<sup>30</sup>
</xref>
<sup>)</sup>. Quantification of ethyl chloroformate-NEFA esters was obtained using
external calibration curves for each NEFA. The two isotopic standards butyric internal
standard (D7, 98&#x000a0;%) and Cambridge Isotope Laboratories, Inc. were used as internal
standard for butyric acid.</p></sec><sec id="sec1-7"><title>Statistical analyses</title><p>Effect of dietary interventions on biochemical and anthropometric parameters was analysed
for completers by multiple linear regression models adjusted for baseline values, with
stepwise backward elimination of the following covariates: age; body fat percentage
(baseline); energy intake in the week preceding the last visit; changes in weight and
physical activity level during the intervention. Log-transformation was applied to
non-normally distributed variables. Comparisons of two means were performed using
<italic>t</italic> tests. Regression coefficients, CI and <italic>P</italic>-values are
reported from the adjusted regression models, while non-adjusted mean values for changes
in biochemical parameters during the intervention are reported in <xref ref-type="table" rid="tab2">Table 2</xref>. Correlation analyses between bacterial gene count and
biochemical measures were analysed by Spearman's rank correlation coefficient. At an
explorative level, the potential effect of diet-induced compositional changes in the gut
microbiota on metabolic markers was examined by separate analyses where MGS that changed
during the intervention were included as explanatory variables in the multiple regression
models. Statistical significance was considered at a threshold value of 0&#x000b7;05. Analyses
were performed using MetaOMinerR package (developed at Metagenopolis, INRA) and JMP
version 9.0.2 (SAS Institute, Inc.).</p></sec></sec><sec sec-type="results" id="sec2"><title>Results</title><p>A total of fifty-three participants completed the study (91&#x000a0;%). Dropout rates were not
significantly different between groups, and no significant differences were found between
dropouts and completers in anthropometric and biochemical characteristics at baseline.
Details on recruitment, randomisation and study flow are shown in <xref ref-type="fig" rid="fig2">Fig. 2</xref>. Baseline characteristics for all the participants by
intervention group are presented in <xref ref-type="table" rid="tab1">Table 1</xref>. There
were no differences in the anthropometric measures between groups; however, the participants
in the <italic>L. paracasei</italic> F19 group had significantly impaired insulin
sensitivity compared with the flaxseed mucilage group, and a significantly lower bacterial
gene count compared with the placebo group. All the participants reported to have consumed
at least 75&#x000a0;% of the study products during the 6 weeks of intervention, and the mean
compliance score was above 90&#x000a0;% in all the groups.<fig id="fig2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Flow chart of the study.</p></caption><graphic xlink:href="S0007114515001786_fig2"/></fig>
<table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Baseline characteristics presented by diet group (Mean values and standard
deviations)</p></caption><alternatives><graphic xlink:href="S0007114515001786_tab1"/><table frame="hsides" rules="groups" id="S0007114515001786_tab1" style="topbot"><thead><tr><th align="left" rowspan="1" colspan="1">
</th><th align="center" rowspan="1" colspan="1">
<italic>Lactobacillus paracasei</italic> F19 (<italic>n</italic> 19)</th><th align="center" rowspan="1" colspan="1">Flaxseed mucilage (<italic>n</italic>
19)</th><th align="center" rowspan="1" colspan="1">Placebo (<italic>n</italic> 20)</th></tr><tr><th align="left" rowspan="1" colspan="1">
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>sd</sc>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">61&#x000b7;4</td><td align="center" rowspan="1" colspan="1">6&#x000b7;5</td><td align="center" rowspan="1" colspan="1">60&#x000b7;6</td><td align="center" rowspan="1" colspan="1">6&#x000b7;4</td><td align="center" rowspan="1" colspan="1">58&#x000b7;5</td><td align="center" rowspan="1" colspan="1">5&#x000b7;3</td></tr><tr><td align="left" rowspan="1" colspan="1">Height (cm)</td><td align="center" rowspan="1" colspan="1">163</td><td align="center" rowspan="1" colspan="1">5&#x000b7;8</td><td align="center" rowspan="1" colspan="1">164</td><td align="center" rowspan="1" colspan="1">7&#x000b7;0</td><td align="center" rowspan="1" colspan="1">165</td><td align="center" rowspan="1" colspan="1">5&#x000b7;7</td></tr><tr><td align="left" rowspan="1" colspan="1">Weight (kg)</td><td align="center" rowspan="1" colspan="1">91&#x000b7;1</td><td align="center" rowspan="1" colspan="1">9&#x000b7;4</td><td align="center" rowspan="1" colspan="1">93&#x000b7;8</td><td align="center" rowspan="1" colspan="1">7&#x000b7;8</td><td align="center" rowspan="1" colspan="1">93&#x000b7;8</td><td align="center" rowspan="1" colspan="1">11&#x000b7;5</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">34&#x000b7;2</td><td align="center" rowspan="1" colspan="1">3&#x000b7;1</td><td align="center" rowspan="1" colspan="1">35&#x000b7;2</td><td align="center" rowspan="1" colspan="1">4&#x000b7;5</td><td align="center" rowspan="1" colspan="1">34&#x000b7;3</td><td align="center" rowspan="1" colspan="1">3&#x000b7;8</td></tr><tr><td align="left" rowspan="1" colspan="1">Waist circumference (cm)</td><td align="center" rowspan="1" colspan="1">105</td><td align="center" rowspan="1" colspan="1">6&#x000b7;8</td><td align="center" rowspan="1" colspan="1">104</td><td align="center" rowspan="1" colspan="1">9&#x000b7;2</td><td align="center" rowspan="1" colspan="1">104</td><td align="center" rowspan="1" colspan="1">11&#x000b7;0</td></tr><tr><td align="left" rowspan="1" colspan="1">IAAT (cm<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">172</td><td align="center" rowspan="1" colspan="1">21&#x000b7;2</td><td align="center" rowspan="1" colspan="1">171</td><td align="center" rowspan="1" colspan="1">28&#x000b7;6</td><td align="center" rowspan="1" colspan="1">169</td><td align="center" rowspan="1" colspan="1">33&#x000b7;4</td></tr><tr><td align="left" rowspan="1" colspan="1">Body fat (%)</td><td align="center" rowspan="1" colspan="1">46&#x000b7;7</td><td align="center" rowspan="1" colspan="1">4&#x000b7;1</td><td align="center" rowspan="1" colspan="1">48&#x000b7;0</td><td align="center" rowspan="1" colspan="1">3&#x000b7;3</td><td align="center" rowspan="1" colspan="1">46&#x000b7;8</td><td align="center" rowspan="1" colspan="1">3&#x000b7;6</td></tr><tr><td align="left" rowspan="1" colspan="1">Energy intake (kJ/d)</td><td align="center" rowspan="1" colspan="1">7824</td><td align="center" rowspan="1" colspan="1">1962</td><td align="center" rowspan="1" colspan="1">6859</td><td align="center" rowspan="1" colspan="1">1922</td><td align="center" rowspan="1" colspan="1">8153</td><td align="center" rowspan="1" colspan="1">1121</td></tr><tr><td align="left" rowspan="1" colspan="1">Protein (E%)</td><td align="center" rowspan="1" colspan="1">18&#x000b7;4</td><td align="center" rowspan="1" colspan="1">3&#x000b7;0</td><td align="center" rowspan="1" colspan="1">19&#x000b7;4</td><td align="center" rowspan="1" colspan="1">4&#x000b7;9</td><td align="center" rowspan="1" colspan="1">19&#x000b7;2</td><td align="center" rowspan="1" colspan="1">2&#x000b7;6</td></tr><tr><td align="left" rowspan="1" colspan="1">Carbohydrates (E%)</td><td align="center" rowspan="1" colspan="1">41&#x000b7;5</td><td align="center" rowspan="1" colspan="1">5&#x000b7;6</td><td align="center" rowspan="1" colspan="1">39&#x000b7;7</td><td align="center" rowspan="1" colspan="1">8&#x000b7;6</td><td align="center" rowspan="1" colspan="1">41&#x000b7;6</td><td align="center" rowspan="1" colspan="1">6&#x000b7;0</td></tr><tr><td align="left" rowspan="1" colspan="1">Fat (E%)</td><td align="center" rowspan="1" colspan="1">34&#x000b7;7</td><td align="center" rowspan="1" colspan="1">6&#x000b7;5</td><td align="center" rowspan="1" colspan="1">35&#x000b7;2</td><td align="center" rowspan="1" colspan="1">6&#x000b7;9</td><td align="center" rowspan="1" colspan="1">36&#x000b7;4</td><td align="center" rowspan="1" colspan="1">5&#x000b7;9</td></tr><tr><td align="left" rowspan="1" colspan="1">24-h-MET-time</td><td align="center" rowspan="1" colspan="1">41&#x000b7;6</td><td align="center" rowspan="1" colspan="1">9&#x000b7;3</td><td align="center" rowspan="1" colspan="1">38&#x000b7;4</td><td align="center" rowspan="1" colspan="1">8&#x000b7;8</td><td align="center" rowspan="1" colspan="1">41&#x000b7;7</td><td align="center" rowspan="1" colspan="1">8&#x000b7;1</td></tr><tr><td align="left" rowspan="1" colspan="1">Fasting plasma glucose (mmol/l)</td><td align="center" rowspan="1" colspan="1">5&#x000b7;89</td><td align="center" rowspan="1" colspan="1">0&#x000b7;76</td><td align="center" rowspan="1" colspan="1">5&#x000b7;75</td><td align="center" rowspan="1" colspan="1">0&#x000b7;90</td><td align="center" rowspan="1" colspan="1">5&#x000b7;81</td><td align="center" rowspan="1" colspan="1">0&#x000b7;77</td></tr><tr><td align="left" rowspan="1" colspan="1">Fasting serum insulin (pmol/l)</td><td align="center" rowspan="1" colspan="1">113</td><td align="center" rowspan="1" colspan="1">55</td><td align="center" rowspan="1" colspan="1">71</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">89</td><td align="center" rowspan="1" colspan="1">56</td></tr><tr><td align="left" rowspan="1" colspan="1">Fasting serum C-peptide (pmol/l)</td><td align="center" rowspan="1" colspan="1">958</td><td align="center" rowspan="1" colspan="1">344</td><td align="center" rowspan="1" colspan="1">713</td><td align="center" rowspan="1" colspan="1">185</td><td align="center" rowspan="1" colspan="1">816</td><td align="center" rowspan="1" colspan="1">385</td></tr><tr><td align="left" rowspan="1" colspan="1">AUC glucose (mmol/l per min)</td><td align="center" rowspan="1" colspan="1">7&#x000b7;6</td><td align="center" rowspan="1" colspan="1">1&#x000b7;7</td><td align="center" rowspan="1" colspan="1">7&#x000b7;0</td><td align="center" rowspan="1" colspan="1">1&#x000b7;7</td><td align="center" rowspan="1" colspan="1">6&#x000b7;8</td><td align="center" rowspan="1" colspan="1">1&#x000b7;0</td></tr><tr><td align="left" rowspan="1" colspan="1">AUC insulin (pmol/l per min)</td><td align="center" rowspan="1" colspan="1">476</td><td align="center" rowspan="1" colspan="1">212</td><td align="center" rowspan="1" colspan="1">331</td><td align="center" rowspan="1" colspan="1">154</td><td align="center" rowspan="1" colspan="1">420</td><td align="center" rowspan="1" colspan="1">303</td></tr><tr><td align="left" rowspan="1" colspan="1">AUC C-peptide (pmol/l per min)</td><td align="center" rowspan="1" colspan="1">3056</td><td align="center" rowspan="1" colspan="1">966</td><td align="center" rowspan="1" colspan="1">2466</td><td align="center" rowspan="1" colspan="1">754</td><td align="center" rowspan="1" colspan="1">2714</td><td align="center" rowspan="1" colspan="1">1204</td></tr><tr><td align="left" rowspan="1" colspan="1">HOMA-IR</td><td align="center" rowspan="1" colspan="1">5&#x000b7;11</td><td align="center" rowspan="1" colspan="1">2&#x000b7;91</td><td align="center" rowspan="1" colspan="1">3&#x000b7;16</td><td align="center" rowspan="1" colspan="1">1&#x000b7;76</td><td align="center" rowspan="1" colspan="1">3&#x000b7;94</td><td align="center" rowspan="1" colspan="1">2&#x000b7;59</td></tr><tr><td align="left" rowspan="1" colspan="1">Matsuda index</td><td align="center" rowspan="1" colspan="1">1&#x000b7;79</td><td align="center" rowspan="1" colspan="1">1&#x000b7;02</td><td align="center" rowspan="1" colspan="1">2&#x000b7;82</td><td align="center" rowspan="1" colspan="1">1&#x000b7;65</td><td align="center" rowspan="1" colspan="1">2&#x000b7;65</td><td align="center" rowspan="1" colspan="1">1&#x000b7;89</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum total cholesterol (mmol/l)</td><td align="center" rowspan="1" colspan="1">6&#x000b7;13</td><td align="center" rowspan="1" colspan="1">1&#x000b7;06</td><td align="center" rowspan="1" colspan="1">6&#x000b7;36</td><td align="center" rowspan="1" colspan="1">0&#x000b7;89</td><td align="center" rowspan="1" colspan="1">5&#x000b7;76</td><td align="center" rowspan="1" colspan="1">0&#x000b7;69</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum HDL-cholesterol (mmol/l)</td><td align="center" rowspan="1" colspan="1">1&#x000b7;46</td><td align="center" rowspan="1" colspan="1">0&#x000b7;26</td><td align="center" rowspan="1" colspan="1">1&#x000b7;40</td><td align="center" rowspan="1" colspan="1">0&#x000b7;22</td><td align="center" rowspan="1" colspan="1">1&#x000b7;56</td><td align="center" rowspan="1" colspan="1">0&#x000b7;42</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum LDL-cholesterol (mmol/l)</td><td align="center" rowspan="1" colspan="1">3&#x000b7;73</td><td align="center" rowspan="1" colspan="1">0&#x000b7;84</td><td align="center" rowspan="1" colspan="1">4&#x000b7;11</td><td align="center" rowspan="1" colspan="1">0&#x000b7;84</td><td align="center" rowspan="1" colspan="1">3&#x000b7;44</td><td align="center" rowspan="1" colspan="1">0&#x000b7;74</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum TAG (mmol/l)</td><td align="center" rowspan="1" colspan="1">1&#x000b7;69</td><td align="center" rowspan="1" colspan="1">0&#x000b7;83</td><td align="center" rowspan="1" colspan="1">1&#x000b7;51</td><td align="center" rowspan="1" colspan="1">0&#x000b7;77</td><td align="center" rowspan="1" colspan="1">1&#x000b7;07</td><td align="center" rowspan="1" colspan="1">0&#x000b7;32</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasma ANGPTL4 (ng/ml)</td><td align="center" rowspan="1" colspan="1">8&#x000b7;16</td><td align="center" rowspan="1" colspan="1">3&#x000b7;08</td><td align="center" rowspan="1" colspan="1">7&#x000b7;77</td><td align="center" rowspan="1" colspan="1">3&#x000b7;06</td><td align="center" rowspan="1" colspan="1">7&#x000b7;59</td><td align="center" rowspan="1" colspan="1">1&#x000b7;36</td></tr><tr><td align="left" rowspan="1" colspan="1">Leucocyte count (10<sup>9</sup>/l)</td><td align="center" rowspan="1" colspan="1">5&#x000b7;55</td><td align="center" rowspan="1" colspan="1">1&#x000b7;05</td><td align="center" rowspan="1" colspan="1">5&#x000b7;46</td><td align="center" rowspan="1" colspan="1">0&#x000b7;92</td><td align="center" rowspan="1" colspan="1">5&#x000b7;60</td><td align="center" rowspan="1" colspan="1">1&#x000b7;64</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasma hsCRP (mg/l)</td><td align="center" rowspan="1" colspan="1">2&#x000b7;90</td><td align="center" rowspan="1" colspan="1">3&#x000b7;78</td><td align="center" rowspan="1" colspan="1">3&#x000b7;73</td><td align="center" rowspan="1" colspan="1">3&#x000b7;69</td><td align="center" rowspan="1" colspan="1">4&#x000b7;14</td><td align="center" rowspan="1" colspan="1">2&#x000b7;90</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum TNF-&#x003b1; (pg/ml)</td><td align="center" rowspan="1" colspan="1">2&#x000b7;66</td><td align="center" rowspan="1" colspan="1">3&#x000b7;53</td><td align="center" rowspan="1" colspan="1">2&#x000b7;64</td><td align="center" rowspan="1" colspan="1">1&#x000b7;60</td><td align="center" rowspan="1" colspan="1">1&#x000b7;81</td><td align="center" rowspan="1" colspan="1">0&#x000b7;70</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasma IL-6 (pg/ml)</td><td align="center" rowspan="1" colspan="1">1&#x000b7;40</td><td align="center" rowspan="1" colspan="1">0&#x000b7;43</td><td align="center" rowspan="1" colspan="1">2&#x000b7;69</td><td align="center" rowspan="1" colspan="1">3&#x000b7;54</td><td align="center" rowspan="1" colspan="1">1&#x000b7;82</td><td align="center" rowspan="1" colspan="1">0&#x000b7;92</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasma LBP (&#x003bc;g/l)</td><td align="center" rowspan="1" colspan="1">18&#x000b7;7</td><td align="center" rowspan="1" colspan="1">5&#x000b7;9</td><td align="center" rowspan="1" colspan="1">19&#x000b7;6</td><td align="center" rowspan="1" colspan="1">7&#x000b7;2</td><td align="center" rowspan="1" colspan="1">18&#x000b7;5</td><td align="center" rowspan="1" colspan="1">7&#x000b7;6</td></tr><tr><td align="left" rowspan="1" colspan="1">Total faecal SCFA (&#x003bc;g/kg)<xref ref-type="table-fn" rid="tab1-fn001">*</xref>
</td><td align="center" rowspan="1" colspan="1">1901</td><td align="center" rowspan="1" colspan="1">1067</td><td align="center" rowspan="1" colspan="1">1556</td><td align="center" rowspan="1" colspan="1">1006</td><td align="center" rowspan="1" colspan="1">1692</td><td align="center" rowspan="1" colspan="1">869</td></tr><tr><td align="left" rowspan="1" colspan="1">Faecal butyric acid (&#x003bc;g/kg)<xref ref-type="table-fn" rid="tab1-fn001">*</xref>
</td><td align="center" rowspan="1" colspan="1">917</td><td align="center" rowspan="1" colspan="1">632</td><td align="center" rowspan="1" colspan="1">892</td><td align="center" rowspan="1" colspan="1">508</td><td align="center" rowspan="1" colspan="1">907</td><td align="center" rowspan="1" colspan="1">443</td></tr><tr><td align="left" rowspan="1" colspan="1">Bacterial gene count<xref ref-type="table-fn" rid="tab1-fn001">*</xref>
</td><td align="center" rowspan="1" colspan="1">556&#x000a0;338</td><td align="center" rowspan="1" colspan="1">144&#x000a0;657</td><td align="center" rowspan="1" colspan="1">618&#x000a0;100</td><td align="center" rowspan="1" colspan="1">114&#x000a0;608</td><td align="center" rowspan="1" colspan="1">646&#x000a0;688</td><td align="center" rowspan="1" colspan="1">77&#x000a0;872</td></tr><tr><td align="left" rowspan="1" colspan="1">Exponential Shannon index<xref ref-type="table-fn" rid="tab1-fn001">*</xref>
</td><td align="center" rowspan="1" colspan="1">139&#x000a0;343</td><td align="center" rowspan="1" colspan="1">59&#x000a0;749</td><td align="center" rowspan="1" colspan="1">176&#x000a0;741</td><td align="center" rowspan="1" colspan="1">59&#x000a0;046</td><td align="center" rowspan="1" colspan="1">179&#x000a0;518</td><td align="center" rowspan="1" colspan="1">53&#x000a0;269</td></tr><tr><td align="left" rowspan="1" colspan="1">Inverse Simpson index<xref ref-type="table-fn" rid="tab1-fn001">*</xref>
</td><td align="center" rowspan="1" colspan="1">44&#x000a0;335</td><td align="center" rowspan="1" colspan="1">25&#x000a0;089</td><td align="center" rowspan="1" colspan="1">55&#x000a0;039</td><td align="center" rowspan="1" colspan="1">24&#x000a0;854</td><td align="center" rowspan="1" colspan="1">55&#x000a0;654</td><td align="center" rowspan="1" colspan="1">23&#x000a0;140</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="tab1-leg001"><p>IAAT, intra-abdominal adipose tissue; E%, energy percentage; 24-h-MET-time, 24-h
metabolic equivalent value; HOMA-IR, homeostatic model assessment of insulin
resistance; ANGPTL4, angiopoietin-like protein 4; hsCRP, high-sensitivity C-reactive
protein; LBP, lipopolysaccharide-binding protein.</p></fn><fn id="tab1-fn001"><label>*</label><p>The analyses are only performed in fifty-three completers.</p></fn></table-wrap-foot></table-wrap>
</p><sec id="sec2-1"><title>Diet-induced changes in biochemical markers</title><p>Multiple linear regression analyses of the effect of dietary intervention on biochemical
markers showed that the intake of flaxseed mucilage over 6 weeks improved insulin
sensitivity as shown by a decrease in the serum C-peptide and insulin response following
the OGTT. The AUC values for serum C-peptide and insulin were 337&#x000a0;pmol/l per min (95&#x000a0;% CI
168&#x000b7;7, 505&#x000b7;1) and 65&#x000b7;9&#x000a0;pmol/l per min (95&#x000a0;% CI 26&#x000b7;5, 105&#x000b7;2) lower compared with placebo
(adjusted values), corresponding to 12 and 13&#x000a0;% improvement within the flaxseed mucilage
group (<xref ref-type="table" rid="tab2">Table 2</xref>). Matsuda's index was increased by
0&#x000b7;4 (95&#x000a0;% CI 0&#x000b7;1, 0&#x000b7;7), compared with placebo (adjusted values); corresponding to 11&#x000a0;%
increase within the flaxseed mucilage group. Markers for lipid metabolism and inflammation
were reduced after 6 weeks in the flaxseed group (<xref ref-type="table" rid="tab2">Table
2</xref>); however, there were no significant differences compared with placebo. There
was no effect of <italic>L. paracasei</italic> F19 on insulin sensitivity, lipid
metabolism, inflammatory markers or anthropometric measures compared with placebo (<xref ref-type="table" rid="tab2">Table 2</xref>).<table-wrap id="tab2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Biochemical characteristics after 6 weeks of dietary intervention and changes from
baseline (Mean values with their standard errors)</p></caption><alternatives><graphic xlink:href="S0007114515001786_tab2"/><table frame="hsides" rules="groups" id="S0007114515001786_tab2" style="topbot"><thead><tr><th align="left" rowspan="1" colspan="1">
</th><th align="center" rowspan="1" colspan="1">
<italic>Lactobacillus paracasei</italic> F19 (<italic>n</italic> 18)</th><th align="center" rowspan="1" colspan="1">Flaxseed mucilage (<italic>n</italic>
19)</th><th align="center" rowspan="1" colspan="1">Placebo (<italic>n</italic> 16)</th><th align="left" rowspan="1" colspan="1">
</th></tr><tr><th align="left" rowspan="1" colspan="1">
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>se</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>se</sc>
</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">
<sc>se</sc>
</th><th align="center" rowspan="1" colspan="1">
<italic>P</italic>
<xref ref-type="table-fn" rid="tab2-fn001">*</xref>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Fasting plasma glucose (mmol/l)</td><td align="center" rowspan="1" colspan="1">5&#x000b7;75</td><td align="center" rowspan="1" colspan="1">0&#x000b7;17</td><td align="center" rowspan="1" colspan="1">5&#x000b7;67</td><td align="center" rowspan="1" colspan="1">0&#x000b7;16</td><td align="center" rowspan="1" colspan="1">5&#x000b7;58</td><td align="center" rowspan="1" colspan="1">0&#x000b7;14</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; Glucose</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;16</td><td align="center" rowspan="1" colspan="1">0&#x000b7;083</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;083</td><td align="center" rowspan="1" colspan="1">0&#x000b7;082</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;30</td><td align="center" rowspan="1" colspan="1">0&#x000b7;14</td><td align="left" rowspan="1" colspan="1">0&#x000b7;524</td></tr><tr><td align="left" rowspan="1" colspan="1">Fasting serum insulin (pmol/l)</td><td align="center" rowspan="1" colspan="1">114</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">72</td><td align="center" rowspan="1" colspan="1">8&#x000b7;0</td><td align="center" rowspan="1" colspan="1">104</td><td align="center" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; Insulin</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;65</td><td align="center" rowspan="1" colspan="1">5&#x000b7;75</td><td align="center" rowspan="1" colspan="1">0&#x000b7;52</td><td align="center" rowspan="1" colspan="1">4&#x000b7;69</td><td align="center" rowspan="1" colspan="1">9&#x000b7;05</td><td align="center" rowspan="1" colspan="1">6&#x000b7;76</td><td align="left" rowspan="1" colspan="1">0&#x000b7;166</td></tr><tr><td align="left" rowspan="1" colspan="1">Fasting serum C-peptide (pmol/l)</td><td align="center" rowspan="1" colspan="1">970</td><td align="center" rowspan="1" colspan="1">91</td><td align="center" rowspan="1" colspan="1">699</td><td align="center" rowspan="1" colspan="1">51</td><td align="center" rowspan="1" colspan="1">917</td><td align="center" rowspan="1" colspan="1">83</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; C-peptide</td><td align="center" rowspan="1" colspan="1">4&#x000b7;9</td><td align="center" rowspan="1" colspan="1">37&#x000b7;0</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;13&#x000b7;7</td><td align="center" rowspan="1" colspan="1">33&#x000b7;3</td><td align="center" rowspan="1" colspan="1">57&#x000b7;7</td><td align="center" rowspan="1" colspan="1">53&#x000b7;3</td><td align="left" rowspan="1" colspan="1">0&#x000b7;258</td></tr><tr><td align="left" rowspan="1" colspan="1">AUC glucose (mmol/l per min)</td><td align="center" rowspan="1" colspan="1">7&#x000b7;49</td><td align="center" rowspan="1" colspan="1">0&#x000b7;43</td><td align="center" rowspan="1" colspan="1">6&#x000b7;91</td><td align="center" rowspan="1" colspan="1">0&#x000b7;38</td><td align="center" rowspan="1" colspan="1">7&#x000b7;00</td><td align="center" rowspan="1" colspan="1">0&#x000b7;29</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; AUC glucose</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;035</td><td align="center" rowspan="1" colspan="1">0&#x000b7;17</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;20</td><td align="center" rowspan="1" colspan="1">0&#x000b7;15</td><td align="center" rowspan="1" colspan="1">0&#x000b7;091</td><td align="center" rowspan="1" colspan="1">0&#x000b7;16</td><td align="left" rowspan="1" colspan="1">0&#x000b7;523</td></tr><tr><td align="left" rowspan="1" colspan="1">AUC insulin (pmol/l per min)</td><td align="center" rowspan="1" colspan="1">504</td><td align="center" rowspan="1" colspan="1">52</td><td align="center" rowspan="1" colspan="1">297</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">481</td><td align="center" rowspan="1" colspan="1">71</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; AUC insulin</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;44</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">39</td><td align="center" rowspan="1" colspan="1">27</td><td align="left" rowspan="1" colspan="1">0&#x000b7;001</td></tr><tr><td align="left" rowspan="1" colspan="1">AUC C-peptide (pmol/l per min)</td><td align="center" rowspan="1" colspan="1">3175</td><td align="center" rowspan="1" colspan="1">252</td><td align="center" rowspan="1" colspan="1">2204</td><td align="center" rowspan="1" colspan="1">132</td><td align="center" rowspan="1" colspan="1">2866</td><td align="center" rowspan="1" colspan="1">283</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; AUC C-peptide</td><td align="center" rowspan="1" colspan="1">110</td><td align="center" rowspan="1" colspan="1">127</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;297</td><td align="center" rowspan="1" colspan="1">93</td><td align="center" rowspan="1" colspan="1">101</td><td align="center" rowspan="1" colspan="1">116</td><td align="left" rowspan="1" colspan="1">0&#x000b7;001</td></tr><tr><td align="left" rowspan="1" colspan="1">HOMA-IR</td><td align="center" rowspan="1" colspan="1">5&#x000b7;07</td><td align="center" rowspan="1" colspan="1">0&#x000b7;70</td><td align="center" rowspan="1" colspan="1">3&#x000b7;06</td><td align="center" rowspan="1" colspan="1">0&#x000b7;36</td><td align="center" rowspan="1" colspan="1">4&#x000b7;00</td><td align="center" rowspan="1" colspan="1">0&#x000b7;65</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; HOMA-IR</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;12</td><td align="center" rowspan="1" colspan="1">0&#x000b7;07</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;10</td><td align="center" rowspan="1" colspan="1">0&#x000b7;051</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;25</td><td align="center" rowspan="1" colspan="1">0&#x000b7;11</td><td align="left" rowspan="1" colspan="1">0&#x000b7;296</td></tr><tr><td align="left" rowspan="1" colspan="1">Matsuda index</td><td align="center" rowspan="1" colspan="1">1&#x000b7;81</td><td align="center" rowspan="1" colspan="1">0&#x000b7;24</td><td align="center" rowspan="1" colspan="1">3&#x000b7;05</td><td align="center" rowspan="1" colspan="1">0&#x000b7;40</td><td align="center" rowspan="1" colspan="1">2&#x000b7;17</td><td align="center" rowspan="1" colspan="1">0&#x000b7;36</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; Matsuda index</td><td align="center" rowspan="1" colspan="1">0&#x000b7;022</td><td align="center" rowspan="1" colspan="1">0&#x000b7;12</td><td align="center" rowspan="1" colspan="1">0&#x000b7;25</td><td align="center" rowspan="1" colspan="1">0&#x000b7;21</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;35</td><td align="center" rowspan="1" colspan="1">0&#x000b7;31</td><td align="left" rowspan="1" colspan="1">0&#x000b7;048</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum total cholesterol (mmol/l)</td><td align="center" rowspan="1" colspan="1">6&#x000b7;24</td><td align="center" rowspan="1" colspan="1">0&#x000b7;28</td><td align="center" rowspan="1" colspan="1">5&#x000b7;89</td><td align="center" rowspan="1" colspan="1">0&#x000b7;21</td><td align="center" rowspan="1" colspan="1">5&#x000b7;72</td><td align="center" rowspan="1" colspan="1">0&#x000b7;17</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; Total cholesterol</td><td align="center" rowspan="1" colspan="1">0&#x000b7;12</td><td align="center" rowspan="1" colspan="1">0&#x000b7;18</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;47</td><td align="center" rowspan="1" colspan="1">0&#x000b7;13</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;11</td><td align="center" rowspan="1" colspan="1">0&#x000b7;13</td><td align="left" rowspan="1" colspan="1">0&#x000b7;154</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum HDL-cholesterol (mmol/l)</td><td align="center" rowspan="1" colspan="1">1&#x000b7;45</td><td align="center" rowspan="1" colspan="1">0&#x000b7;056</td><td align="center" rowspan="1" colspan="1">1&#x000b7;34</td><td align="center" rowspan="1" colspan="1">0&#x000b7;047</td><td align="center" rowspan="1" colspan="1">1&#x000b7;54</td><td align="center" rowspan="1" colspan="1">0&#x000b7;089</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; HDL-cholesterol</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;0067</td><td align="center" rowspan="1" colspan="1">0&#x000b7;036</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;058</td><td align="center" rowspan="1" colspan="1">0&#x000b7;040</td><td align="center" rowspan="1" colspan="1">0&#x000b7;013</td><td align="center" rowspan="1" colspan="1">0&#x000b7;041</td><td align="left" rowspan="1" colspan="1">0&#x000b7;150</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum LDL-cholesterol (mmol/l)</td><td align="center" rowspan="1" colspan="1">3&#x000b7;81</td><td align="center" rowspan="1" colspan="1">0&#x000b7;23</td><td align="center" rowspan="1" colspan="1">3&#x000b7;72</td><td align="center" rowspan="1" colspan="1">0&#x000b7;20</td><td align="center" rowspan="1" colspan="1">3&#x000b7;46</td><td align="center" rowspan="1" colspan="1">0&#x000b7;17</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; LDL-cholesterol</td><td align="center" rowspan="1" colspan="1">0&#x000b7;085</td><td align="center" rowspan="1" colspan="1">0&#x000b7;15</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;39</td><td align="center" rowspan="1" colspan="1">0&#x000b7;10</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;089</td><td align="center" rowspan="1" colspan="1">0&#x000b7;11</td><td align="left" rowspan="1" colspan="1">0&#x000b7;068<xref ref-type="table-fn" rid="tab2-fn002">&#x02020;</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum TAG (mmol/l)</td><td align="center" rowspan="1" colspan="1">1&#x000b7;96</td><td align="center" rowspan="1" colspan="1">0&#x000b7;22</td><td align="center" rowspan="1" colspan="1">1&#x000b7;48</td><td align="center" rowspan="1" colspan="1">0&#x000b7;12</td><td align="center" rowspan="1" colspan="1">1&#x000b7;16</td><td align="center" rowspan="1" colspan="1">0&#x000b7;079</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; TAG</td><td align="center" rowspan="1" colspan="1">0&#x000b7;24</td><td align="center" rowspan="1" colspan="1">0&#x000b7;14</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;028</td><td align="center" rowspan="1" colspan="1">0&#x000b7;14</td><td align="center" rowspan="1" colspan="1">0&#x000b7;13</td><td align="center" rowspan="1" colspan="1">0&#x000b7;057</td><td align="left" rowspan="1" colspan="1">0&#x000b7;205</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasma ANGPTL4 (ng/ml)</td><td align="center" rowspan="1" colspan="1">7&#x000b7;80</td><td align="center" rowspan="1" colspan="1">0&#x000b7;67</td><td align="center" rowspan="1" colspan="1">6&#x000b7;92</td><td align="center" rowspan="1" colspan="1">0&#x000b7;60</td><td align="center" rowspan="1" colspan="1">7&#x000b7;19</td><td align="center" rowspan="1" colspan="1">0&#x000b7;47</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; ANGPTL4</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;25</td><td align="center" rowspan="1" colspan="1">0&#x000b7;33</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;85</td><td align="center" rowspan="1" colspan="1">0&#x000b7;46</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;69</td><td align="center" rowspan="1" colspan="1">0&#x000b7;52</td><td align="left" rowspan="1" colspan="1">0&#x000b7;142</td></tr><tr><td align="left" rowspan="1" colspan="1">Leucocyte count (10<sup>9</sup>/l).</td><td align="center" rowspan="1" colspan="1">5&#x000b7;41</td><td align="center" rowspan="1" colspan="1">0&#x000b7;25</td><td align="center" rowspan="1" colspan="1">5&#x000b7;14</td><td align="center" rowspan="1" colspan="1">0&#x000b7;26</td><td align="center" rowspan="1" colspan="1">5&#x000b7;50</td><td align="center" rowspan="1" colspan="1">0&#x000b7;34</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; Leucocyte count</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;18</td><td align="center" rowspan="1" colspan="1">0&#x000b7;17</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;33</td><td align="center" rowspan="1" colspan="1">0&#x000b7;22</td><td align="center" rowspan="1" colspan="1">0&#x000b7;07</td><td align="center" rowspan="1" colspan="1">0&#x000b7;15</td><td align="left" rowspan="1" colspan="1">0&#x000b7;290</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasma hsCRP (mg/l)</td><td align="center" rowspan="1" colspan="1">3&#x000b7;43</td><td align="center" rowspan="1" colspan="1">0&#x000b7;95</td><td align="center" rowspan="1" colspan="1">2&#x000b7;68</td><td align="center" rowspan="1" colspan="1">0&#x000b7;80</td><td align="center" rowspan="1" colspan="1">2&#x000b7;89</td><td align="center" rowspan="1" colspan="1">0&#x000b7;66</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; hsCRP</td><td align="center" rowspan="1" colspan="1">0&#x000b7;43</td><td align="center" rowspan="1" colspan="1">0&#x000b7;26</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;91</td><td align="center" rowspan="1" colspan="1">0&#x000b7;20</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;1&#x000b7;25</td><td align="center" rowspan="1" colspan="1">0&#x000b7;45</td><td align="left" rowspan="1" colspan="1">0&#x000b7;036<xref ref-type="table-fn" rid="tab2-fn002">&#x02020;</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Serum TNF-&#x003b1;</td><td align="center" rowspan="1" colspan="1">2&#x000b7;79</td><td align="center" rowspan="1" colspan="1">0&#x000b7;78</td><td align="center" rowspan="1" colspan="1">2&#x000b7;60</td><td align="center" rowspan="1" colspan="1">0&#x000b7;43</td><td align="center" rowspan="1" colspan="1">1&#x000b7;63</td><td align="center" rowspan="1" colspan="1">0&#x000b7;14</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; TNF-&#x003b1;</td><td align="center" rowspan="1" colspan="1">0&#x000b7;056</td><td align="center" rowspan="1" colspan="1">0&#x000b7;13</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;043</td><td align="center" rowspan="1" colspan="1">0&#x000b7;15</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;011</td><td align="center" rowspan="1" colspan="1">0&#x000b7;16</td><td align="left" rowspan="1" colspan="1">0&#x000b7;419</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasma IL-6</td><td align="center" rowspan="1" colspan="1">1&#x000b7;54</td><td align="center" rowspan="1" colspan="1">0&#x000b7;12</td><td align="center" rowspan="1" colspan="1">2&#x000b7;10</td><td align="center" rowspan="1" colspan="1">0&#x000b7;36</td><td align="center" rowspan="1" colspan="1">1&#x000b7;73</td><td align="center" rowspan="1" colspan="1">0&#x000b7;25</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; IL-6</td><td align="center" rowspan="1" colspan="1">0&#x000b7;10</td><td align="center" rowspan="1" colspan="1">0&#x000b7;091</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;59</td><td align="center" rowspan="1" colspan="1">0&#x000b7;49</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;0&#x000b7;16</td><td align="center" rowspan="1" colspan="1">0&#x000b7;16</td><td align="left" rowspan="1" colspan="1">0&#x000b7;644</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasma LBP (&#x003bc;g/l)</td><td align="center" rowspan="1" colspan="1">19&#x000b7;7</td><td align="center" rowspan="1" colspan="1">1&#x000b7;5</td><td align="center" rowspan="1" colspan="1">18&#x000b7;1</td><td align="center" rowspan="1" colspan="1">1&#x000b7;5</td><td align="center" rowspan="1" colspan="1">16&#x000b7;3</td><td align="center" rowspan="1" colspan="1">1&#x000b7;5</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; LBP</td><td align="center" rowspan="1" colspan="1">0&#x000b7;56</td><td align="center" rowspan="1" colspan="1">0&#x000b7;82</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;1&#x000b7;51</td><td align="center" rowspan="1" colspan="1">0&#x000b7;84</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;1&#x000b7;88</td><td align="center" rowspan="1" colspan="1">0&#x000b7;93</td><td align="left" rowspan="1" colspan="1">0&#x000b7;221</td></tr><tr><td align="left" rowspan="1" colspan="1">Total faecal SCFA (&#x003bc;g/kg)</td><td align="center" rowspan="1" colspan="1">1730</td><td align="center" rowspan="1" colspan="1">224</td><td align="center" rowspan="1" colspan="1">1477</td><td align="center" rowspan="1" colspan="1">190</td><td align="center" rowspan="1" colspan="1">1685</td><td align="center" rowspan="1" colspan="1">231</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; SCFA</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;171</td><td align="center" rowspan="1" colspan="1">242</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;79</td><td align="center" rowspan="1" colspan="1">239</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;6&#x000b7;9</td><td align="center" rowspan="1" colspan="1">145</td><td align="left" rowspan="1" colspan="1">0&#x000b7;890</td></tr><tr><td align="left" rowspan="1" colspan="1">Faecal butyric acid (&#x003bc;g/kg)</td><td align="center" rowspan="1" colspan="1">789</td><td align="center" rowspan="1" colspan="1">128</td><td align="center" rowspan="1" colspan="1">806</td><td align="center" rowspan="1" colspan="1">93</td><td align="center" rowspan="1" colspan="1">837</td><td align="center" rowspan="1" colspan="1">89</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x00394; Butyric acid</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;128</td><td align="center" rowspan="1" colspan="1">148</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;86</td><td align="center" rowspan="1" colspan="1">157</td><td align="center" rowspan="1" colspan="1">&#x02212;&#x000a0;70</td><td align="center" rowspan="1" colspan="1">94</td><td align="left" rowspan="1" colspan="1">0&#x000b7;811</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="tab2-leg001"><p>&#x00394;, change during the 6 weeks of dietary intervention (unadjusted values);
HOMA-IR, homeostatic model assessment of insulin resistance; ANGPTL4,
angiopoietin-like protein 4; hsCRP, high-sensitivity C-reactive protein; LBP,
lipopolysaccharide-binding protein.</p></fn><fn id="tab2-fn001"><label>*</label><p>
<italic>P</italic>-values are reported from linear regression models of the effect
of dietary group on the specified parameters, when adjusted for relevant
covariates including baseline values.</p></fn><fn id="tab2-fn002"><label>&#x02020;</label><p>The difference is to be found between the F19 and flaxseed mucilage group, but
not when these are compared with placebo by Student's <italic>t</italic> test.</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec id="sec2-2"><title>Diet-induced changes in gut microbiota composition</title><p>Sequenced reads mapped against the MetaHIT gene catalogue of 3&#x000b7;3 million genes at a
normal range of 61 (<sc>se</sc> 6)&#x000a0;%. Of the fifty-three participants, forty-nine (92&#x000b7;5&#x000a0;%)
had high gene count and four (7&#x000b7;5&#x000a0;%) had low gene count; two in the group allocated to
<italic>L. paracasei</italic> F19 and two in the group allocated to flaxseed mucilage. A
prediction model for bacterial richness based on six bacterial species, introduced by
Cotillard <italic>et al.</italic>
<sup>(</sup>
<xref rid="ref4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>)</sup>, was applied to the current data set and an AUC value of 0&#x000b7;94 was obtained.</p><p>At baseline, total bacterial gene count, which is a measure of gut bacterial richness,
correlated negatively with total cholesterol (<italic>r</italic> &#x02212;&#x000a0;0&#x000b7;28,
<italic>P</italic>=&#x000a0;0&#x000b7;043), LDL-cholesterol (<italic>r</italic> &#x02212;&#x000a0;0&#x000b7;30,
<italic>P</italic>=&#x000a0;0&#x000b7;029), leucocytes count (<italic>r</italic> &#x02212;&#x000a0;0&#x000b7;34,
<italic>P</italic>=&#x000a0;0&#x000b7;015) and aspartate aminotransferase (<italic>r</italic> &#x02212;&#x000a0;0&#x000b7;33,
<italic>P</italic>=&#x000a0;0&#x000b7;018), and tended to correlate negatively with AUC glucose
(<italic>r</italic> &#x02212;&#x000a0;0&#x000b7;25, <italic>P</italic>=&#x000a0;0&#x000b7;069) and alanine aminotransferase
(<italic>r</italic> &#x02212;&#x000a0;0&#x000b7;24, <italic>P</italic>=&#x000a0;0&#x000b7;091).</p><p>Within the flaxseed mucilage group, bacterial gene count decreased with 47&#x000a0;271 genes over
6 weeks (95&#x000a0;% CI &#x02212;&#x000a0;82&#x000a0;176, &#x02212;&#x000a0;12&#x000a0;366, <italic>P</italic>=&#x000a0;0&#x000b7;011); however, this change was
not significantly compared with placebo (<italic>P</italic>=&#x000a0;0&#x000b7;144). Bacterial gene count
did not change within the <italic>L. paracasei</italic> F19 group
(<italic>P</italic>=&#x000a0;0&#x000b7;473). The gene loss following intake of flaxseed mucilage for 6
weeks was confirmed by measures of &#x003b1; diversity; when evaluated by the exponential of
Shannon diversity index and Simpson's inverse index, the decrease in diversity was 38&#x000a0;010
(95&#x000a0;% CI &#x02212;&#x000a0;64&#x000a0;473, &#x02212;&#x000a0;11&#x000a0;546, <italic>P</italic>=&#x000a0;0&#x000b7;007) and 17&#x000a0;515 (95&#x000a0;% CI &#x02212;&#x000a0;30&#x000a0;992,
&#x02212;&#x000a0;4038, <italic>P</italic>=&#x000a0;0&#x000b7;014), respectively.</p><p>Comparison of microbiota composition at baseline and after 6 weeks of intervention with
<italic>L. paracasei</italic> F19 showed alterations in faecal abundance of 2493
bacterial genes assigned to two MGS that increased during the intervention relative to
baseline. These were identified as the species <italic>Eubacterium rectale</italic> and
<italic>Ruminococcus torques</italic>. The proportion of total distributions of
<italic>E. rectale</italic> recovered after analysis increased 3&#x000b7;3 times
(<italic>P</italic>=&#x000a0;0&#x000b7;003) and <italic>R. torques</italic> increased 4&#x000b7;5 times
(<italic>P</italic>&#x0003c;&#x000a0;0&#x000b7;001).</p><p>The placebo intervention led to altered faecal abundance of 7436 genes assigned to six
MGS (<italic>P</italic>&#x0003c;&#x000a0;0&#x000b7;01), where the relative abundance of four MGS
(<italic>Roseburia hominis</italic>, two Clostridiales and one unknown) decreased and
the relative abundance of two MGS (<italic>Eubacterium ventriosum</italic> and one
unknown) increased.</p><p>Comparison of microbiota composition at baseline and after 6 weeks of intervention with
flaxseed mucilage showed alterations in faecal abundance of 41&#x000a0;090 bacterial genes
assigned to thirty-three MGS, the relative abundance of twenty-four MGS decreased and nine
MGS increased (<xref ref-type="table" rid="tab3">Table 3</xref> and <xref ref-type="fig" rid="fig3">Fig. 3</xref>). Of the thirty-three MGS that changed, twenty-four were
identified at phylum level or below. Eight of the MGS identified as decreasing during the
intervention were assigned to the <italic>Faecalibacterium</italic> genus, among which
three <italic>F. prausnitzii</italic> species with sequence homology to the strains
<italic>F. prausnitzii</italic> A2-165, <italic>F. prausnitzii</italic> SL3/3 and
<italic>F. cf. prausnitzii</italic> KLE1255. The proportion of total distributions of
these three species decreased 0&#x000b7;6 times (<italic>P</italic>&#x0003c;&#x000a0;0&#x000b7;01). Moreover,
<italic>Ruminococcus lactaris</italic> decreased 0&#x000b7;9 times during the flaxseed mucilage
intervention (<italic>P</italic>=&#x000a0;0&#x000b7;005).<table-wrap id="tab3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Gut bacteria changes in relative abundance after 6 weeks of intervention with 10&#x000a0;g
flaxseed mucilage</p></caption><alternatives><graphic xlink:href="S0007114515001786_tab3"/><table frame="hsides" rules="groups" id="S0007114515001786_tab3" style="topbot"><thead><tr><td align="left" rowspan="1" colspan="1">Taxonomic level</td><td align="left" rowspan="1" colspan="1">
<italic>n</italic>
</td><td align="left" rowspan="1" colspan="1">Annotation</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Decreased relative abundance</td><td align="left" rowspan="1" colspan="1">
</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">Species</td><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">
<italic>Ruminococcus lactaris</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Species</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">
<italic>Faecalibacterium prausnitzii</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Genus</td><td align="center" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">
<italic>Faecalibacterium</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Genus</td><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">
<italic>Ruminococcus</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Genus</td><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">
<italic>Eubacterium</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Family</td><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">Erysipelotrichaceae</td></tr><tr><td align="left" rowspan="1" colspan="1">Family</td><td align="center" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">Lachnospiraceae</td></tr><tr><td align="left" rowspan="1" colspan="1">Order</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Clostridiales</td></tr><tr><td align="left" rowspan="1" colspan="1">Phylum</td><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">Firmicutes</td></tr><tr><td align="left" rowspan="1" colspan="1">
</td><td align="center" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="left" rowspan="1" colspan="1">Increased relative abundance</td><td align="center" rowspan="1" colspan="1">
</td><td align="left" rowspan="1" colspan="1">
</td></tr><tr><td align="left" rowspan="1" colspan="1">Species</td><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">
<italic>Bilophila wadsworthia</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Species</td><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">
<italic>Parabacteroides merdae</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Species</td><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">
<italic>Parabacteroides johnsonii</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Genus</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">
<italic>Clostridium</italic>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
</td><td align="center" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">Unknown</td></tr></tbody></table></alternatives></table-wrap>
<fig id="fig3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>The presence and abundance of the thirty-three species that differed significantly
before and after 6 weeks of intervention with flaxseed mucilage. Each barcode
illustrates the abundance of a species, either enriched at baseline (top) or week 6
(bottom): samples are in columns (same order for both time points) and the fifty
&#x02018;tracer&#x02019; genes are in rows. Gene abundance is indicated by colour gradient from
white (not detected) over blue, green and yellow to red (most abundant). Taxonomical
information is given for each species; the number of genes within each metagenomic
species is given in parenthesis. Fdr, Benjamini Hochberg multiple testing correction
of paired Wilcoxon tests; unk., unknown taxonomy.</p></caption><graphic xlink:href="S0007114515001786_fig3"/></fig>
</p><p>Three of the nine MGS that increased in relative abundance after the flaxseed mucilage
intervention were assigned to the <italic>Clostridium</italic> genus (<xref ref-type="table" rid="tab3">Table 3</xref> and <xref ref-type="fig" rid="fig3">Fig.
3</xref>). Furthermore, three MGS were identified to species level as <italic>Bilophila
wadsworthia</italic>, <italic>Parabacteroides merdae</italic> and
<italic>Parabacteroides johnsonii</italic>. The proportion of total distributions of
these three species increased 2&#x000b7;6 times (<italic>P</italic>&#x0003c;&#x000a0;0&#x000b7;001), 3&#x000b7;6 times
(<italic>P</italic>=&#x000a0;0&#x000b7;004) and 4&#x000b7;7 times (<italic>P</italic>&#x0003c;&#x000a0;0&#x000b7;001),
respectively.</p></sec><sec id="sec2-3"><title>Effect of gut microbiota on the improvement in insulin sensitivity</title><p>When exploring the role of relative changes in the gut microbiota on improvement in
insulin sensitivity in the flaxseed mucilage group, the MGS that changed during the
intervention were included in the multiple regression models in separate analyses.
Relative changes in the MGS did not contribute to the effect of the flaxseed mucilage
intervention on Matsuda index or AUC values for insulin and C-peptide, when separate
analyses were performed where the delta values for the individual MGS were included in the
model as explanatory variables.</p></sec><sec id="sec2-4"><title>Adverse events</title><p>During the initial 4 weeks of the intervention, more adverse events were reported in the
flaxseed group (<italic>n</italic> 11), compared with the placebo group
(<italic>n</italic> 4; <italic>P</italic>=&#x000a0;0&#x000b7;023), while there was no difference in the
occurrence of adverse events between the placebo and the <italic>L. paracasei</italic> F19
group (<italic>n</italic> 8; <italic>P</italic>=&#x000a0;0&#x000b7;297). The adverse events reported
following the flaxseed intervention were increased flatulence and changed bowel habits
with more frequent defecation and looser stool consistency. After 6 weeks, these symptoms
were diminishing and only reported in seven participants, which was not different from the
placebo group. There was no difference between the adverse events reported following the
probiotic and placebo intervention that included both more frequent and less-frequent
defecation. No serious adverse events were registered during the study.</p></sec></sec><sec sec-type="discussion" id="sec3"><title>Discussion</title><p>The present study shows that daily intake of flaxseed mucilage over 6 weeks can improve
insulin sensitivity and modify the gut microbiota in individuals with obesity. The relative
decrease in the abundance of <italic>F. prausnitzii</italic> species following intake of
flaxseed mucilage is surprising given the improvement in insulin sensitivity. Previous
metagenomic studies have suggested that <italic>F. prausnitzii</italic> is more abundant in
healthy individuals than in individuals with T2D<sup>(</sup>
<xref rid="ref3" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>,</sup>
<xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup>. In addition, prebiotics have been shown to induce a parallel increase in the
faecal abundance of <italic>F. prausnitzii</italic> and improvement in insulin sensitivity
in individuals with obesity<sup>(</sup>
<xref rid="ref11" ref-type="bibr">
<sup>11</sup>
</xref>
<sup>)</sup>. A beneficial effect of <italic>F. prausnitzii</italic> on insulin sensitivity
has been hypothesised to be due to its role as a major producer of the SCFA butyrate<sup>(</sup>
<xref rid="ref31" ref-type="bibr">
<sup>31</sup>
</xref>
<sup>)</sup>, as butyrate seems to have an anti-inflammatory potential that might improve
obesity-related metabolic complications such as insulin resistance<sup>(</sup>
<xref rid="ref32" ref-type="bibr">
<sup>32</sup>
</xref>
<sup>)</sup>. The relative lower abundance of <italic>F. prausnitzii</italic> following
intake of flaxseed mucilage is supported by the reduction observed in faecal butyrate
content and by results from a previous study performed in rats, where fermentation of
flaxseed fibres had been shown to yield a remarkably low proportion of butyrate, when
compared with other dietary fibres<sup>(</sup>
<xref rid="ref22" ref-type="bibr">
<sup>22</sup>
</xref>
<sup>)</sup>.</p><p>The improvement in insulin sensitivity following intake of flaxseed mucilage was
accompanied by reductions in markers for inflammation and dyslipidaemia, although these
changes were non-significant, compared with the placebo group. The gut microbiota has been
implicated in the low-grade inflammation that characterises the progression from obesity to
metabolic disease, as translocation of bacterial toxins, such as lipopolysaccharides, into
the circulation can activate inflammatory pathways<sup>(</sup>
<xref rid="ref33" ref-type="bibr">
<sup>33</sup>
</xref>
<sup>,</sup>
<xref rid="ref34" ref-type="bibr">
<sup>34</sup>
</xref>
<sup>)</sup>. Impaired gut barrier function can be caused by adipocyte-derived inflammatory
cytokines<sup>(</sup>
<xref rid="ref35" ref-type="bibr">
<sup>35</sup>
</xref>
<sup>)</sup>, and increased translocation of lipopolysaccharides can be induced by a
high-fat diet<sup>(</sup>
<xref rid="ref36" ref-type="bibr">
<sup>36</sup>
</xref>
<sup>,</sup>
<xref rid="ref37" ref-type="bibr">
<sup>37</sup>
</xref>
<sup>)</sup>. Thus, it is likely that the gut is an important mediator in obesity-related
systemic inflammation. Prebiotic-induced modulation of the gut microbiota has been proposed
to inhibit translocation of lipopolysaccharides based on observations in mice<sup>(</sup>
<xref rid="ref38" ref-type="bibr">
<sup>38</sup>
</xref>
<sup>)</sup>; however, it is still unclear to what degree such mechanisms apply to human
subjects. Since the decrease in LBP, hsCRP, TNF-&#x003b1; and IL-6 in the present study did not
differ between the flaxseed mucilage and the placebo group, the improvement in insulin
sensitivity did not appear to be mediated through inhibition of lipopolysaccharide
translocation.</p><p>The design of the present study allowed us to explore whether the improvement in insulin
sensitivity following intake of flaxseed mucilage could be due to a gut microbiota
modulating effect. However, analyses showed that the changes in relative abundance of
bacterial species induced by flaxseed mucilage did not explain any of the changes in the
biochemical markers. When this is considered in relation to the flaxseed mucilage-induced
changes in the microbiota that, based on the existing literature, are not in line with an
improved host metabolic phenotype, we conclude that changes in the gut microbiota following
intake of flaxseed mucilage do not appear to be a contributing factor to the beneficial
effect of flaxseed mucilage on insulin sensitivity. Previously, it has been shown that daily
intake of 5&#x000a0;g flaxseed mucilage reduced fasting blood glucose, total cholesterol and
LDL-cholesterol in patients with T2D after 12 weeks<sup>(</sup>
<xref rid="ref20" ref-type="bibr">
<sup>20</sup>
</xref>
<sup>)</sup>, and reduced total- and LDL-cholesterol in healthy individuals after 1
week<sup>(</sup>
<xref rid="ref21" ref-type="bibr">
<sup>21</sup>
</xref>
<sup>)</sup>. In addition, acute meal tests with flaxseed mucilage have been shown to
suppress postprandial blood glucose, insulin and lipid responses<sup>(</sup>
<xref rid="ref19" ref-type="bibr">
<sup>19</sup>
</xref>
<sup>,</sup>
<xref rid="ref39" ref-type="bibr">
<sup>39</sup>
</xref>
<sup>)</sup>. The beneficial metabolic effects of flaxseed mucilage observed in these
previous studies and in the present study would then appear to be due to the ability of the
soluble viscous fibres to delay gastric emptying and inhibit nutrient absorption rather than
their ability to induce specific changes in the gut microbiota. Although, it cannot be
excluded that the effect on insulin sensitivity was mediated through undetected bacterial
species or changes in proteins and metabolites present in the gut that were not measured in
the present study. The dominating molecular pathways in the bacterial species that increased
during the flaxseed mucilage intervention are involved in pro-inflammatory signalling and
managing of oxidative stress, pathways that have previously been suggested to be enriched in
individuals with obesity-related metabolic diseases<sup>(</sup>
<xref rid="ref5" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>)</sup>. This shift towards a gut microbiome with a more pro-inflammatory potential
might be explained by the fact that the flaxseed mucilage intervention provided more Cd in
the diet. Despite that the Cd content in the flaxseed mucilage was at a concentration
considered harmless to human health (0&#x000b7;113&#x000a0;mg/kg)<sup>(</sup>
<xref rid="ref40" ref-type="bibr">
<sup>40</sup>
</xref>
<sup>)</sup>, it still might have induced modifications in the gut microbiome. This has been
observed in previous studies in mice, where alterations were induced in the gut microbiome
following administration of environmental relevant low doses of Cd in drinking-water over
3&#x02013;8 weeks<sup>(</sup>
<xref rid="ref41" ref-type="bibr">
<sup>41</sup>
</xref>
<sup>&#x02013;</sup>
<xref rid="ref43" ref-type="bibr">
<sup>43</sup>
</xref>
<sup>)</sup>.</p><p>This study showed a very limited effect of <italic>L. paracasei</italic> F19
(9&#x000b7;4&#x000a0;&#x000d7;&#x000a0;10<sup>10</sup> colony-forming units/dose) on the gut microbiota and metabolic
markers, which were non-significant compared with the placebo group. The storage of
<italic>L. paracasei</italic> F19 was optimised to ensure that the probiotic strain was
alive at ingestion. The diary kept by the participants indicated that they were highly
compliant to the intervention.</p><p>A combined effect of this probiotic strain on both metagenomic and metabolic markers in
human subjects has not been explored previously. In mice, <italic>L. paracasei</italic> F19
has been shown to affect the immune system and expression of genes involved in energy
homeostasis and insulin sensitivity<sup>(</sup>
<xref rid="ref44" ref-type="bibr">
<sup>44</sup>
</xref>
<sup>)</sup>, and to regulate body fat storage and lipoprotein metabolism<sup>(</sup>
<xref rid="ref45" ref-type="bibr">
<sup>45</sup>
</xref>
<sup>)</sup>. Observational studies in human subjects have suggested that <italic>L.
paracasei</italic> is associated with normal weight<sup>(</sup>
<xref rid="ref15" ref-type="bibr">
<sup>15</sup>
</xref>
<sup>)</sup> and negatively correlated with fasting blood glucose<sup>(</sup>
<xref rid="ref16" ref-type="bibr">
<sup>16</sup>
</xref>
<sup>)</sup> despite that several other <italic>Lactobacillus</italic> species have been
suggested to be associated with obesity<sup>(</sup>
<xref rid="ref16" ref-type="bibr">
<sup>16</sup>
</xref>
<sup>,</sup>
<xref rid="ref46" ref-type="bibr">
<sup>46</sup>
</xref>
<sup>,</sup>
<xref rid="ref47" ref-type="bibr">
<sup>47</sup>
</xref>
<sup>)</sup> and T2D<sup>(</sup>
<xref rid="ref7" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup>. It is possible that we would have observed an effect of the probiotic
intervention if it had been administered as part of a fermentable milk product, as a
fermentable food matrix could potentially enhance probiotic efficacy<sup>(</sup>
<xref rid="ref48" ref-type="bibr">
<sup>48</sup>
</xref>
<sup>)</sup>. A study among elderly has shown that daily intake of a fermented milk product
with <italic>L. paracasei</italic> F19 (5&#x000b7;25&#x000a0;&#x000d7;&#x000a0;10<sup>8</sup> colony-forming units) over 4
weeks stimulates the growth of other <italic>Lactobacillus</italic> species in the gut<sup>(</sup>
<xref rid="ref49" ref-type="bibr">
<sup>49</sup>
</xref>
<sup>)</sup>. However, no effect on other <italic>Lactobacillus</italic> species was
observed following 6 weeks of intake of <italic>L. paracasei</italic> F19 in the present
study, although it cannot be excluded that the abundance of <italic>Lactobacillus</italic>
species not included in the gene catalogue did change<sup>(</sup>
<xref rid="ref29" ref-type="bibr">
<sup>29</sup>
</xref>
<sup>)</sup>.</p><p>The inclusion criteria in the present study were designed in order to recruit individuals
at increased risk of metabolic diseases. Previous metagenomic studies have suggested that
individuals with a metabolic risk profile are characterised by low gut microbiome
richness<sup>(</sup>
<xref rid="ref4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="ref5" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>)</sup>. The obese participants in these previous studies were comparable to the
participants in the present study from a phenotype perspective; thus, it is surprising that
only 8&#x000a0;% of the individuals in the present study had low gut microbiome richness as opposed
to 23&#x02013;40&#x000a0;% in the other cohorts<sup>(</sup>
<xref rid="ref4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="ref5" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>)</sup>. The protocol for handling and analyses of microbiota samples were similar to
the samples handling in the MetaHIT study<sup>(</sup>
<xref rid="ref5" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>)</sup>; however, it is possible that deviations in the prevalence of low microbiome
richness between the cohorts can be explained by differences in habitual dietary habits.
Yet, the negative correlations identified between bacterial gene count and metabolic risk
markers support an association between gut microbiome richness and metabolic health. As does
the lower microbiome richness detected at baseline in the participants allocated to
<italic>L. paracasei</italic> F19, who were characterised by impaired insulin sensitivity,
compared with the two other groups. This is interesting as the prediction model based on six
bacterial species that has previously been demonstrated as a tool to identify individuals
with low microbiome richness in two other obese cohorts<sup>(</sup>
<xref rid="ref4" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>,</sup>
<xref rid="ref5" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>)</sup> also showed high specificity and sensitivity in this cohort.</p><p>In conclusion, the present study shows that intake of flaxseed mucilage improves insulin
sensitivity and changes the gut microbiota in obese postmenopausal women, but suggests that
the effect on insulin sensitivity is independent of the flaxseed mucilage-induced changes in
abundance of bacterial species.</p></sec><sec sec-type="supplementary-material" id="sec4"><title>Supplementary material</title><supplementary-material content-type="local-data" id="S0007114515001786sup001"><p>For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S0007114515001786.</p><media xlink:href="S0007114515001786sup001.jpg" mimetype="JPG" mime-subtype="jpeg" orientation="portrait" id="d35e3323" position="anchor"><caption><p>click here to view supplementary material</p></caption></media></supplementary-material></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>The authors thank the study participants; the kitchen staff, dieticians, laboratory
technicians, good clinical practice coordinator and students involved in the project and the
staff from the INRA/MetaGenoPolis: Florence Levenez and Jo&#x000eb;l Dor&#x000e9; for sample preparation;
Nathalie Galleron and Benoit Quinquis for microbiome sequencing; Jean-Michel Batto and
Pierre Leonard for informatics. In addition to Sander Kersten, Division of Human Nutrition,
Wageningen University, who kindly provided the protocol and guidance for the ANGPTL4
analyses. The study is part of The Lundbeck Foundation Centre for Applied Medical Genomics
in Personalized Disease Prediction, Prevention and Care (<uri xlink:type="simple" xlink:href="http://www.lucamp.org">http://www.LuCAMP.org</uri>).</p><p>The present study was financially supported by The Lundbeck Foundation Centre for Applied
Medical Genomics in Personalized Disease Prediction, Prevention and Care (<uri xlink:type="simple" xlink:href="http://www.lucamp.org">http://www.LuCAMP.org</uri>), and
The Danish Dairy Board. Arla Foods amba delivered the probiotic product and provided
additional funding. Metagenopolis is funded by the Investissement d'Avenir grant
ANR-11-DPBS-0001.</p><p>The authors' contributions are as follows: L. K. B., T. H., O. P., A. A. and L. H. L.
designed the research; L. K. B. and L. H. L. conducted the research; L. K. B., E. L. C., E.
P., N. P., S. K., T. B., J. H., T. K. D., S. D. E. and L. H. L. contributed to the analysis
and interpretation of the data; L. K. B. wrote the paper; L. K. B., E. L. C. and L. H. L.
holds primary responsibility for the final content. All authors read and approved the final
manuscript.</p><p>L. K. B., T. B., A. A. and L. H. L., as employed at the Department of Nutrition, Exercise
and Sports, University of Copenhagen, received funding for research from the Arla Foods amba
and the Danish Dairy Board. A. A. is a consultant or a member of the advisory boards for
BioCare Copenhagen, DK; Basic Research, USA; Global Dairy Platform, USA; S-Biotek, DK. He
holds rights to patents regarding properties of flaxseed registered in collaboration with
the University of Copenhagen. J. H. is employed by Arla Strategic Innovation Centre,
Stockholm, Sweden. E. L. C., E. P., N. P., S. K., T. K. D., T. H., O. P. and S. D. E.
declared no conflicts of interest.</p></ack><ref-list id="reflist1"><title>References</title><ref id="ref1"><label>1</label><mixed-citation publication-type="book">
<collab>World Health Organization</collab> (<year>2012</year>) <source>World Health
Statistics</source>. <publisher-loc>Geneva</publisher-loc>:
<publisher-name>WHO</publisher-name>.</mixed-citation></ref><ref id="ref2"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Turnbaugh</surname><given-names>PJ</given-names></name>, <name><surname>Hamady</surname><given-names>M</given-names></name>, <name><surname>Yatsunenko</surname><given-names>T</given-names></name>, <etal>et al.</etal> (<year>2009</year>) <article-title>A core gut microbiome in
obese and lean twins</article-title>. <source>Nature</source>
<volume>457</volume>, <fpage>480</fpage>&#x02013;<lpage>484</lpage>.<pub-id pub-id-type="pmid">19043404</pub-id></mixed-citation></ref><ref id="ref3"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Qin</surname><given-names>J</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Cai</surname><given-names>Z</given-names></name>, <etal>et al.</etal> (<year>2012</year>) <article-title>A metagenome-wide
association study of gut microbiota in type 2 diabetes</article-title>. <source>Nature</source>
<volume>490</volume>, <fpage>55</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">23023125</pub-id></mixed-citation></ref><ref id="ref4"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Cotillard</surname><given-names>A</given-names></name>, <name><surname>Kennedy</surname><given-names>SP</given-names></name>, <name><surname>Kong</surname><given-names>LC</given-names></name>, <etal>et al.</etal> (<year>2013</year>) <article-title>Dietary intervention
impact on gut microbial gene richness</article-title>. <source>Nature</source>
<volume>500</volume>, <fpage>585</fpage>&#x02013;<lpage>588</lpage>.<pub-id pub-id-type="pmid">23985875</pub-id></mixed-citation></ref><ref id="ref5"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Le Chatelier</surname><given-names>E</given-names></name>, <name><surname>Nielsen</surname><given-names>T</given-names></name>, <name><surname>Qin</surname><given-names>J</given-names></name>, <etal>et al.</etal> (<year>2013</year>) <article-title>Richness of human gut
microbiome correlates with metabolic markers</article-title>. <source>Nature</source>
<volume>500</volume>, <fpage>541</fpage>&#x02013;<lpage>546</lpage>.<pub-id pub-id-type="pmid">23985870</pub-id></mixed-citation></ref><ref id="ref6"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Karlsson</surname><given-names>FH</given-names></name>, <name><surname>Fak</surname><given-names>F</given-names></name>, <name><surname>Nookaew</surname><given-names>I</given-names></name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Symptomatic
atherosclerosis is associated with an altered gut metagenome</article-title>.
<source>Nat Commun</source>
<volume>3</volume>, <fpage>1245</fpage>.<pub-id pub-id-type="pmid">23212374</pub-id></mixed-citation></ref><ref id="ref7"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Karlsson</surname><given-names>FH</given-names></name>, <name><surname>Tremaroli</surname><given-names>V</given-names></name>, <name><surname>Nookaew</surname><given-names>I</given-names></name>, <etal>et al.</etal> (<year>2013</year>) <article-title>Gut metagenome in European
women with normal, impaired and diabetic glucose control</article-title>. <source>Nature</source>
<volume>498</volume>, <fpage>99</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="pmid">23719380</pub-id></mixed-citation></ref><ref id="ref8"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Backhed</surname><given-names>F</given-names></name>, <name><surname>Ding</surname><given-names>H</given-names></name>, <name><surname>Wang</surname><given-names>T</given-names></name>, <etal>et al.</etal> (<year>2004</year>) <article-title>The gut microbiota as an
environmental factor that regulates fat storage</article-title>. <source>Proc Natl Acad
Sci U S A</source>
<volume>101</volume>, <fpage>15718</fpage>&#x02013;<lpage>15723</lpage>.<pub-id pub-id-type="pmid">15505215</pub-id></mixed-citation></ref><ref id="ref9"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Turnbaugh</surname><given-names>PJ</given-names></name>, <name><surname>Ley</surname><given-names>RE</given-names></name>, <name><surname>Mahowald</surname><given-names>MA</given-names></name>, <etal>et al.</etal> (<year>2006</year>) <article-title>An obesity-associated gut
microbiome with increased capacity for energy harvest</article-title>. <source>Nature</source>
<volume>444</volume>, <fpage>1027</fpage>&#x02013;<lpage>1031</lpage>.<pub-id pub-id-type="pmid">17183312</pub-id></mixed-citation></ref><ref id="ref10"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Vrieze</surname><given-names>A</given-names></name>, <name><surname>Van Nood</surname><given-names>E</given-names></name>, <name><surname>Holleman</surname><given-names>F</given-names></name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Transfer of intestinal
microbiota from lean donors increases insulin sensitivity in individuals with metabolic
syndrome</article-title>. <source>Gastroenterology</source>
<volume>143</volume>, <fpage>913</fpage>&#x02013;<lpage>916.e7</lpage>.<pub-id pub-id-type="pmid">22728514</pub-id></mixed-citation></ref><ref id="ref11"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Dewulf</surname><given-names>EM</given-names></name>, <name><surname>Cani</surname><given-names>PD</given-names></name>, <name><surname>Claus</surname><given-names>SP</given-names></name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Insight into the prebiotic
concept: lessons from an exploratory, double blind intervention study with insulin-type
fructans in obese women</article-title>. <source>Gut</source>
<volume>62</volume>, <fpage>1112</fpage>&#x02013;<lpage>1121</lpage>.<pub-id pub-id-type="pmid">23135760</pub-id></mixed-citation></ref><ref id="ref12"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Vulevic</surname><given-names>J</given-names></name>, <name><surname>Juric</surname><given-names>A</given-names></name>, <name><surname>Tzortzis</surname><given-names>G</given-names></name>, <etal>et al.</etal> (<year>2013</year>) <article-title>A mixture of
<italic>trans</italic>-galactooligosaccharides reduces markers of metabolic syndrome and
modulates the fecal microbiota and immune function of overweight adults</article-title>.
<source>J Nutr</source>
<volume>143</volume>, <fpage>324</fpage>&#x02013;<lpage>331</lpage>.<pub-id pub-id-type="pmid">23303873</pub-id></mixed-citation></ref><ref id="ref13"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Gordon</surname><given-names>JI</given-names></name> (<year>2012</year>) <article-title>Honor thy gut symbionts redux</article-title>.
<source>Science</source>
<volume>336</volume>, <fpage>1251</fpage>&#x02013;<lpage>1253</lpage>.<pub-id pub-id-type="pmid">22674326</pub-id></mixed-citation></ref><ref id="ref14"><label>14</label><mixed-citation publication-type="journal">
<name><surname>de Vrese</surname><given-names>M</given-names></name> &#x00026; <name><surname>Schrezenmeir</surname><given-names>J</given-names></name> (<year>2008</year>) <article-title>Probiotics, prebiotics, and
synbiotics</article-title>. <source>Adv Biochem Eng Biotechnol</source>
<volume>111</volume>, <fpage>1</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">18461293</pub-id></mixed-citation></ref><ref id="ref15"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Million</surname><given-names>M</given-names></name>, <name><surname>Maraninchi</surname><given-names>M</given-names></name>, <name><surname>Henry</surname><given-names>M</given-names></name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Obesity-associated gut
microbiota is enriched in <italic>Lactobacillus reuteri</italic> and depleted in
<italic>Bifidobacterium animalis</italic> and <italic>Methanobrevibacter
smithii</italic>
</article-title>. <source>Int J Obes (Lond)</source>
<volume>36</volume>, <fpage>817</fpage>&#x02013;<lpage>825</lpage>.<pub-id pub-id-type="pmid">21829158</pub-id></mixed-citation></ref><ref id="ref16"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Stsepetova</surname><given-names>J</given-names></name>, <name><surname>Sepp</surname><given-names>E</given-names></name>, <name><surname>Kolk</surname><given-names>H</given-names></name>, <etal>et al.</etal> (<year>2011</year>) <article-title>Diversity and metabolic
impact of intestinal <italic>Lactobacillus</italic> species in healthy adults and the
elderly</article-title>. <source>Br J Nutr</source>
<volume>105</volume>, <fpage>1235</fpage>&#x02013;<lpage>1244</lpage>.<pub-id pub-id-type="pmid">21303568</pub-id></mixed-citation></ref><ref id="ref17"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Gibson</surname><given-names>GR</given-names></name>, <name><surname>Scott</surname><given-names>KP</given-names></name>, <name><surname>Rastall</surname><given-names>RA</given-names></name>, <etal>et al.</etal> (<year>2010</year>) <article-title>Dietary prebiotics:
current status and new definition</article-title>. <source>IFIS Funct Foods Bull</source>
<volume>7</volume>, <fpage>1</fpage>&#x02013;<lpage>19</lpage>.</mixed-citation></ref><ref id="ref18"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Hall</surname><given-names>C</given-names><suffix>3rd</suffix></name>, <name><surname>Tulbek</surname><given-names>MC</given-names></name> &#x00026; <name><surname>Xu</surname><given-names>Y</given-names></name> (<year>2006</year>) <article-title>Flaxseed</article-title>. <source>Adv Food Nutr
Res</source>
<volume>51</volume>, <fpage>1</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="pmid">17011474</pub-id></mixed-citation></ref><ref id="ref19"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Cunnane</surname><given-names>SC</given-names></name>, <name><surname>Ganguli</surname><given-names>S</given-names></name>, <name><surname>Menard</surname><given-names>C</given-names></name>, <etal>et al.</etal> (<year>1993</year>) <article-title>High &#x003b1;-linolenic acid
flaxseed (<italic>Linum usitatissimum</italic>): some nutritional properties in
humans</article-title>. <source>Br J Nutr</source>
<volume>69</volume>, <fpage>443</fpage>&#x02013;<lpage>453</lpage>.<pub-id pub-id-type="pmid">8098222</pub-id></mixed-citation></ref><ref id="ref20"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Thakur</surname><given-names>G</given-names></name>, <name><surname>Mitra</surname><given-names>A</given-names></name>, <name><surname>Pal</surname><given-names>K</given-names></name>, <etal>et al.</etal> (<year>2009</year>) <article-title>Effect of flaxseed gum on
reduction of blood glucose and cholesterol in type 2 diabetic patients</article-title>.
<source>Int J Food Sci Nutr</source>
<volume>60</volume>, <fpage>126</fpage>&#x02013;<lpage>136</lpage>.<pub-id pub-id-type="pmid">19548163</pub-id></mixed-citation></ref><ref id="ref21"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Kristensen</surname><given-names>M</given-names></name>, <name><surname>Jensen</surname><given-names>MG</given-names></name>, <name><surname>Aarestrup</surname><given-names>J</given-names></name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Flaxseed dietary fibers
lower cholesterol and increase fecal fat excretion, but magnitude of effect depend on
food type</article-title>. <source>Nutr Metab (Lond)</source>
<volume>9</volume>, <fpage>8</fpage>.<pub-id pub-id-type="pmid">22305169</pub-id></mixed-citation></ref><ref id="ref22"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Berggren</surname><given-names>AM</given-names></name>, <name><surname>Bj&#x000f6;rck</surname><given-names>IME</given-names></name> &#x00026; <name><surname>Nyman</surname><given-names>MGL</given-names></name> (<year>1993</year>) <article-title>Short-chain fatty acid content and pH in caecum
of rats given various sources of carbohydrates</article-title>. <source>J Sci Food Agric</source>
<volume>63</volume>, <fpage>397</fpage>&#x02013;<lpage>406</lpage>.</mixed-citation></ref><ref id="ref23"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Treuth</surname><given-names>MS</given-names></name>, <name><surname>Hunter</surname><given-names>GR</given-names></name> &#x00026; <name><surname>Kekes-Szabo</surname><given-names>T</given-names></name> (<year>1995</year>) <article-title>Estimating intraabdominal adipose tissue in
women by dual-energy X-ray absorptiometry</article-title>. <source>Am J Clin Nutr</source>
<volume>62</volume>, <fpage>527</fpage>&#x02013;<lpage>532</lpage>.<pub-id pub-id-type="pmid">7661113</pub-id></mixed-citation></ref><ref id="ref24"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Aadahl</surname><given-names>M</given-names></name> &#x00026; <name><surname>Jorgensen</surname><given-names>T</given-names></name> (<year>2003</year>) <article-title>Validation of a new self-report instrument for
measuring physical activity</article-title>. <source>Med Sci Sports Exerc</source>
<volume>35</volume>, <fpage>1196</fpage>&#x02013;<lpage>1202</lpage>.<pub-id pub-id-type="pmid">12840642</pub-id></mixed-citation></ref><ref id="ref25"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Matthews</surname><given-names>DR</given-names></name>, <name><surname>Hosker</surname><given-names>JP</given-names></name>, <name><surname>Rudenski</surname><given-names>AS</given-names></name>, <etal>et al.</etal> (<year>1985</year>) <article-title>Homeostasis model
assessment: insulin resistance and beta-cell function from fasting plasma glucose and
insulin concentrations in man</article-title>. <source>Diabetologia</source>
<volume>28</volume>, <fpage>412</fpage>&#x02013;<lpage>419</lpage>.<pub-id pub-id-type="pmid">3899825</pub-id></mixed-citation></ref><ref id="ref26"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Matsuda</surname><given-names>M</given-names></name> &#x00026; <name><surname>DeFronzo</surname><given-names>RA</given-names></name> (<year>1999</year>) <article-title>Insulin sensitivity indices obtained from oral
glucose tolerance testing: comparison with the euglycemic insulin clamp</article-title>.
<source>Diabetes Care</source>
<volume>22</volume>, <fpage>1462</fpage>&#x02013;<lpage>1470</lpage>.<pub-id pub-id-type="pmid">10480510</pub-id></mixed-citation></ref><ref id="ref27"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Suau</surname><given-names>A</given-names></name>, <name><surname>Bonnet</surname><given-names>R</given-names></name>, <name><surname>Sutren</surname><given-names>M</given-names></name>, <etal>et al.</etal> (<year>1999</year>) <article-title>Direct analysis of genes
encoding 16S rRNA from complex communities reveals many novel molecular species within
the human gut</article-title>. <source>Appl Environ Microbiol</source>
<volume>65</volume>, <fpage>4799</fpage>&#x02013;<lpage>4807</lpage>.<pub-id pub-id-type="pmid">10543789</pub-id></mixed-citation></ref><ref id="ref28"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Godon</surname><given-names>JJ</given-names></name>, <name><surname>Zumstein</surname><given-names>E</given-names></name>, <name><surname>Dabert</surname><given-names>P</given-names></name>, <etal>et al.</etal> (<year>1997</year>) <article-title>Molecular microbial
diversity of an anaerobic digestor as determined by small-subunit rDNA sequence
analysis</article-title>. <source>Appl Environ Microbiol</source>
<volume>63</volume>, <fpage>2802</fpage>&#x02013;<lpage>2813</lpage>.<pub-id pub-id-type="pmid">9212428</pub-id></mixed-citation></ref><ref id="ref29"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Qin</surname><given-names>J</given-names></name>, <name><surname>Li</surname><given-names>R</given-names></name>, <name><surname>Raes</surname><given-names>J</given-names></name>, <etal>et al.</etal> (<year>2010</year>) <article-title>A human gut microbial gene
catalogue established by metagenomic sequencing</article-title>. <source>Nature</source>
<volume>464</volume>, <fpage>59</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="pmid">20203603</pub-id></mixed-citation></ref><ref id="ref30"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Amer</surname><given-names>B</given-names></name>, <name><surname>Nebel</surname><given-names>C</given-names></name>, <name><surname>Bertram</surname><given-names>HC</given-names></name>, <etal>et al.</etal> (<year>2013</year>) <article-title>Novel method for
quantification of individual free fatty acids in milk using an in-solution
derivatisation approach and gas chromatography mass spectrometry</article-title>.
<source>Int Dairy J</source>
<volume>32</volume>, <fpage>199</fpage>&#x02013;<lpage>203</lpage>.</mixed-citation></ref><ref id="ref31"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Louis</surname><given-names>P</given-names></name> &#x00026; <name><surname>Flint</surname><given-names>HJ</given-names></name> (<year>2009</year>) <article-title>Diversity, metabolism and microbial ecology of
butyrate-producing bacteria from the human large intestine</article-title>. <source>FEMS
Microbiol Lett</source>
<volume>294</volume>, <fpage>1</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">19222573</pub-id></mixed-citation></ref><ref id="ref32"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Brahe</surname><given-names>LK</given-names></name>, <name><surname>Astrup</surname><given-names>A</given-names></name> &#x00026; <name><surname>Larsen</surname><given-names>LH</given-names></name> (<year>2013</year>) <article-title>Is butyrate the link between diet, intestinal
microbiota and obesity-related metabolic diseases?</article-title>
<source>Obes Rev</source>
<volume>14</volume>, <fpage>950</fpage>&#x02013;<lpage>959</lpage>.<pub-id pub-id-type="pmid">23947604</pub-id></mixed-citation></ref><ref id="ref33"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Sun</surname><given-names>L</given-names></name>, <name><surname>Yu</surname><given-names>Z</given-names></name>, <name><surname>Ye</surname><given-names>X</given-names></name>, <etal>et al.</etal> (<year>2010</year>) <article-title>A marker of endotoxemia is
associated with obesity and related metabolic disorders in apparently healthy
Chinese</article-title>. <source>Diabetes Care</source>
<volume>33</volume>, <fpage>1925</fpage>&#x02013;<lpage>1932</lpage>.<pub-id pub-id-type="pmid">20530747</pub-id></mixed-citation></ref><ref id="ref34"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Pussinen</surname><given-names>PJ</given-names></name>, <name><surname>Havulinna</surname><given-names>AS</given-names></name>, <name><surname>Lehto</surname><given-names>M</given-names></name>, <etal>et al.</etal> (<year>2011</year>) <article-title>Endotoxemia is associated
with an increased risk of incident diabetes</article-title>. <source>Diabetes Care</source>
<volume>34</volume>, <fpage>392</fpage>&#x02013;<lpage>397</lpage>.<pub-id pub-id-type="pmid">21270197</pub-id></mixed-citation></ref><ref id="ref35"><label>35</label><mixed-citation publication-type="journal">
<name><surname>de Kort</surname><given-names>S</given-names></name>, <name><surname>Keszthelyi</surname><given-names>D</given-names></name> &#x00026; <name><surname>Masclee</surname><given-names>AA</given-names></name> (<year>2011</year>) <article-title>Leaky gut and diabetes mellitus: what is the
link?</article-title>
<source>Obes Rev</source>
<volume>12</volume>, <fpage>449</fpage>&#x02013;<lpage>458</lpage>.<pub-id pub-id-type="pmid">21382153</pub-id></mixed-citation></ref><ref id="ref36"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Erridge</surname><given-names>C</given-names></name>, <name><surname>Attina</surname><given-names>T</given-names></name>, <name><surname>Spickett</surname><given-names>CM</given-names></name>, <etal>et al.</etal> (<year>2007</year>) <article-title>A high-fat meal induces
low-grade endotoxemia: evidence of a novel mechanism of postprandial
inflammation</article-title>. <source>Am J Clin Nutr</source>
<volume>86</volume>, <fpage>1286</fpage>&#x02013;<lpage>1292</lpage>.<pub-id pub-id-type="pmid">17991637</pub-id></mixed-citation></ref><ref id="ref37"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Ghoshal</surname><given-names>S</given-names></name>, <name><surname>Witta</surname><given-names>J</given-names></name>, <name><surname>Zhong</surname><given-names>J</given-names></name>, <etal>et al.</etal> (<year>2009</year>) <article-title>Chylomicrons promote
intestinal absorption of lipopolysaccharides</article-title>. <source>J Lipid Res</source>
<volume>50</volume>, <fpage>90</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="pmid">18815435</pub-id></mixed-citation></ref><ref id="ref38"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Cani</surname><given-names>PD</given-names></name>, <name><surname>Neyrinck</surname><given-names>AM</given-names></name>, <name><surname>Fava</surname><given-names>F</given-names></name>, <etal>et al.</etal> (<year>2007</year>) <article-title>Selective increases of
bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through
a mechanism associated with endotoxaemia</article-title>. <source>Diabetologia</source>
<volume>50</volume>, <fpage>2374</fpage>&#x02013;<lpage>2383</lpage>.<pub-id pub-id-type="pmid">17823788</pub-id></mixed-citation></ref><ref id="ref39"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Kristensen</surname><given-names>M</given-names></name>, <name><surname>Savorani</surname><given-names>F</given-names></name>, <name><surname>Christensen</surname><given-names>S</given-names></name>, <etal>et al.</etal> (<year>2013</year>) <article-title>Flaxseed dietary fibers
suppress postprandial lipemia and appetite sensation in young men</article-title>.
<source>Nutr Metab Cardiovasc Dis</source>
<volume>23</volume>, <fpage>136</fpage>&#x02013;<lpage>143</lpage>.<pub-id pub-id-type="pmid">21802266</pub-id></mixed-citation></ref><ref id="ref40"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Tarpila</surname><given-names>A</given-names></name>, <name><surname>Wennberg</surname><given-names>T</given-names></name> &#x00026; <name><surname>Tarpila</surname><given-names>S</given-names></name> (<year>2005</year>) <article-title>Flaxseed as a functional food</article-title>.
<source>Curr Top Nutraceutical Res</source>
<volume>3</volume>, <fpage>167</fpage>&#x02013;<lpage>188</lpage>.</mixed-citation></ref><ref id="ref41"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Fazeli</surname><given-names>M</given-names></name>, <name><surname>Hassanzadeh</surname><given-names>P</given-names></name> &#x00026; <name><surname>Alaei</surname><given-names>S</given-names></name> (<year>2011</year>) <article-title>Cadmium chloride exhibits a profound toxic
effect on bacterial microflora of the mice gastrointestinal tract</article-title>.
<source>Hum Exp Toxicol</source>
<volume>30</volume>, <fpage>152</fpage>&#x02013;<lpage>159</lpage>.<pub-id pub-id-type="pmid">20488844</pub-id></mixed-citation></ref><ref id="ref42"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Breton</surname><given-names>J</given-names></name>, <name><surname>Massart</surname><given-names>S</given-names></name>, <name><surname>Vandamme</surname><given-names>P</given-names></name>, <etal>et al.</etal> (<year>2013</year>) <article-title>Ecotoxicology inside the
gut: impact of heavy metals on the mouse microbiome</article-title>. <source>BMC
Pharmacol Toxicol</source>
<volume>14</volume>, <fpage>62</fpage>.<pub-id pub-id-type="pmid">24325943</pub-id></mixed-citation></ref><ref id="ref43"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>K</given-names></name>, <etal>et al.</etal> (<year>2014</year>) <article-title>Exposing to cadmium stress
cause profound toxic effect on microbiota of the mice intestinal tract</article-title>.
<source>PLOS ONE</source>
<volume>9</volume>, <fpage>e85323</fpage>.<pub-id pub-id-type="pmid">24498261</pub-id></mixed-citation></ref><ref id="ref44"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Nerstedt</surname><given-names>A</given-names></name>, <name><surname>Nilsson</surname><given-names>EC</given-names></name>, <name><surname>Ohlson</surname><given-names>K</given-names></name>, <etal>et al.</etal> (<year>2007</year>) <article-title>Administration of
<italic>Lactobacillus</italic> evokes coordinated changes in the intestinal expression
profile of genes regulating energy homeostasis and immune phenotype in
mice</article-title>. <source>Br J Nutr</source>
<volume>97</volume>, <fpage>1117</fpage>&#x02013;<lpage>1127</lpage>.<pub-id pub-id-type="pmid">17433125</pub-id></mixed-citation></ref><ref id="ref45"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Aronsson</surname><given-names>L</given-names></name>, <name><surname>Huang</surname><given-names>Y</given-names></name>, <name><surname>Parini</surname><given-names>P</given-names></name>, <etal>et al.</etal> (<year>2010</year>) <article-title>Decreased fat storage by
<italic>Lactobacillus paracasei</italic> is associated with increased levels of
angiopoietin-like 4 protein (ANGPTL4)</article-title>. <source>PLoS One</source>
<volume>5</volume>, <fpage>e13087</fpage>.<pub-id pub-id-type="pmid">20927337</pub-id></mixed-citation></ref><ref id="ref46"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Armougom</surname><given-names>F</given-names></name>, <name><surname>Henry</surname><given-names>M</given-names></name>, <name><surname>Vialettes</surname><given-names>B</given-names></name>, <etal>et al.</etal> (<year>2009</year>) <article-title>Monitoring bacterial
community of human gut microbiota reveals an increase in <italic>Lactobacillus</italic>
in obese patients and Methanogens in anorexic patients</article-title>. <source>PLoS One</source>
<volume>4</volume>, <fpage>e7125</fpage>.<pub-id pub-id-type="pmid">19774074</pub-id></mixed-citation></ref><ref id="ref47"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Million</surname><given-names>M</given-names></name>, <name><surname>Angelakis</surname><given-names>E</given-names></name>, <name><surname>Paul</surname><given-names>M</given-names></name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Comparative meta-analysis
of the effect of <italic>Lactobacillus</italic> species on weight gain in humans and
animals</article-title>. <source>Microb Pathog</source>
<volume>53</volume>, <fpage>100</fpage>&#x02013;<lpage>108</lpage>.<pub-id pub-id-type="pmid">22634320</pub-id></mixed-citation></ref><ref id="ref48"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Sanders</surname><given-names>ME</given-names></name> &#x00026; <name><surname>Marco</surname><given-names>ML</given-names></name> (<year>2010</year>) <article-title>Food formats for effective delivery of
probiotics</article-title>. <source>Annu Rev Food Sci Technol</source>
<volume>1</volume>, <fpage>65</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="pmid">22129330</pub-id></mixed-citation></ref><ref id="ref49"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Sullivan</surname><given-names>&#x000c5;</given-names></name>, <name><surname>Palmgren</surname><given-names>A</given-names></name> &#x00026; <name><surname>Nord</surname><given-names>CE</given-names></name> (<year>2001</year>) <article-title>Effect of <italic>Lactobacillus
paracasei</italic> on intestinal colonisation of Lactobacilli, Bifidobacteria and
<italic>Clostridium difficile</italic> in elderly persons</article-title>.
<source>Anaerobe</source>
<volume>7</volume>, <fpage>67</fpage>&#x02013;<lpage>70</lpage>.</mixed-citation></ref></ref-list></back></article>